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ABTRACT 
Endothelial cells apoptosis is a hallmark for h u m a n cardiovascular diseases, 
such as hypertension, atherosclerosis, and diabetes. Clinical studies imply a 
positive role of endothelial cells apoptosis in the formation of atherosclerotic 
plaques. Recent studies indicate that endothelial cells apoptosis contributes to 
the development of atherosclerosis by increasing the permeability of 
endothelial monolayer and subsequent uptake of lipids in the vessel wall. 
W h e n endothelial cells undergoing apoptosis, apoptotic blebs can be detected 
and the isolated blebs can release monocyte adhesion molecules, leading to 
binding of endothelial cells to monocytes. This process is proven to 
accompany with an increased oxidative stress. In addition, endothelial cell 
apoptosis also participates in the occurrence of endothelial dysfunction by 
reduction of nitric oxide bioavailability. Critically, apoptosis of endothelial cell 
can disturb the integrity of endothelial monolayer, leading to different vascular 
events; therefore, studies on mechanistic pathways involved in endothelial cell 
apoptosis m a y help to identify new targets for therapeutic intervention in 
cardiovascular diseases. 
Reactive oxygen species (ROS) is known to induce apoptosis in various types 
of cells, including endothelial cells and vascular smooth muscle cells, 
suggesting the potential role of R O S in vascular cell apoptosis. R O S can be 
synthesized endogenously in endothelial cells or vascular smooth muscle cells 
upon stimulation with risk factors, such as angiotensin II, bone morphogenic 
protein-4 (BMP4) and oxidized low density lipoprotein. NAD(P)H oxidase is 
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one of the important intracellular sources of R O S and it can be up-regulated by 
pro-inflammatory factors in cardiovascular diseases. Intracellular R O S can 
then activate a variety of signaling molecules, such as M A P K s . 
M A P K s .including p38 M A P K , E R K and JNK, which are redox-sensitive and is 
involved in many cellular events, such as differentiation, proliferation and 
apoptosis when triggered by hydrogen peroxide or disturbed blood flow. This 
then raises a question whether ROS-mediated M A P K s activation is involved in 
endothelial cell apoptosis caused by pro-inflammatory factors. 
B M P 4 , although, is originally discovered as a bone growth factor, it can exert 
inflammatory effects in blood vessels through increasing oxidative stress. 
B M P 2 , B M P 4 and B M P 6 have been detected in atherosclerotic plaques. 
Recent studies suggest the novel inflammatory role of B M P 4 in cardiovascular 
pathogenesis by showing that B M P 4 induces monocyte adhesion in response 
to oscillatory shear stress in endothelial cells. In addition, limited studies in 
vitro show that B M P 4 impairs endothelial function through the activation of 
NAD(P)H oxidase. Despite of these studies, the mechanisms accounting for 
BMP4-induced vascular inflammation are largely unclear. 
The present study made use of human umbilical cord vein endothelial cells 
(HUVECs) and isolated rat aortic endothelial cells (RAECs) as cell models to 
evaluate the apoptotic effect of exogenously applied B M P 4 in endothelial cells 
and to investigate the possible intracellular signaling pathway(s) initiated by 
B M P 4 . In order to achieve the above-stated aims, a combination of 
experimental approaches was employed and they included methods used for 
cell death assessment, molecular biology technique, imaging, and 
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immunohistochemistry. 
Exogenous B M P 4 caused significant apoptosis of H U V E C s and R A E C s 
following 24-hours exposure. The apoptotic effects on both cell types were 
totally prevented by noggin (BMP4 antagonist), apocynin [NAD(P)H oxidase 
inhibitor], tiron plus D E T C A (ROS scavengers), S B 202190 (p38 M A P K 
inhibitor) and S P 600125 (JNK inhibitor). Western blot analysis showed that 
B M P 4 treatment (i) increased the expression of cleaved caspase-3 after 24 
hour exposure, without affecting the expression on bcl-2, cleaved caspase-8 
and caspase-9, (ii) rapidly increased generation of R O S after a 30-min brief 
exposure as detected by dihydroethidium (DHE) fluorescence imaging, which 
can be abolished by noggin, apocynin, or trion plus D E T C A , (iii) increased the 
phosphoylation level of p38 M A P K at 2-hour exposure and phosphorylation of 
J N K 1 at 4-hour exposure. Moreover, the activation of both J N K and p38 
M A P K could be also abolished by noggin, apocynin, or tiron plus D E T C A , 
implying a central role of R O S in the activation of p38 M A P K and JNK. Further 
examination revealed a cross-talk between p38 M A P K and JNK. J N K 
activation w a s prevented by p38 M A P K inhibitor while J N K inhibitor did not 
alter the phosphorylation level of p38 M A P K , thus suggesting that J N K 
activation was dependent on the activation of p38 M A P K in BMP4-induced 
endothelial cells apoptosis. 
In the present study, I also obtained evidence showing that B M P 4 induced 
endothelial cells apoptosis in a caspase-3-dependent manner. It appears that 
B M P 4 triggers increased formation of R O S rapidly through the activation of 
NAD(P)H oxidase and R O S then activates the p38 M A P K and J N K pathways. 
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M y result show that the activation of J N K depends on ROS-stimulated 
phosphorylation of p38 M A P K , resulting in apoptosis of endothelial cells. 
In conclusion, the present study demonstrates that the release of superoxide 
anions triggered by B M P 4 initiates a cascade of intracellular events in 
H U V E C s and R A E C s as proposed as the following order culminating in 
apoptosis of both types of endothelial cells: NAD(P)H oxidase-derived R O S 
activates p38 M A P K and in turn activates J N K 1. The latter activates 
caspase-3 causing apoptotic responses. The present results indicate that 
B M P 4 m a y act as another novel but important pro-inflammatory molecule and 


































apocynin [NAD(P)H 氧化酶抑製劑]，tiron 力卩 D E T C A (ROS 消除劑），SB 
ix 
202190 (p38MAPK 抑製劑)和 SP 600125 (JNK 抑製劑）所抑製。Western 
blot結果顯示BMP4導致：i)在24小時BMP4處理後’增加分裂caspase-3的 
表達’但沒有改變bcl-2'分裂caspase-8和caspase-9的表達，ii)在30分鐘 
B M P 4處理後’ 二氢乙锭(DHE)熒光顯示BMP4迅速增加R0S的產生。R0S的 
產生可被noggin，apocynin和tiron加DETCA所抑製，iii)在2小時BMP4處 
理後，增加p38 MAPK磷酸化水平及在4小時後’增加了 J N K磷酸化水平 ° 
而且 noggin, apocynin 和 tiron 加 D E T C A 可抑製 p38 M A P K 和 JNK 磷酸化’ 
意味著BMP4弓丨起的ROS在p38 M A P K和 J N K激活中扮演了重要的角色 °更 





p38 M A P K和及其下游的 J N K。結果顯示 J N K激活是依賴 R O S剌激之 p 3 8 
MAPK磷酸化’導致血管內皮細胞凋亡° 
綜所上述’本硏究揭示了 B M P 4在內皮細胞 H U V E C s和 R A E C s中觸發 R O S 
之產生後’所弓丨發一連串的細胞內信號傳遞途徑如下:NAD(P)H氧化酶產生的 
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Chapter I) Introduction 
CHAPTER I 
Introduction 
1.1) Endothelial cells function 
Endothelium is the single layer of cells lining the lumen of blood vessels, 
locating between the circulating blood and the underlying vascular smooth 
muscle cells (VSMC). In response to shear stress and various chemical 
agonists, such as circulating hormones and growth factors, endothelial cells 
control vascular tone by producing either endothelium-derived relaxing factors 
(EDRF), such as nitric oxide (NO), prostaglandin (PGI
2
), and 
endothelium-derived hyperpolarizating factors (EDHF) or endothelium-derived 
contracting factors, such as reactive oxygen species (ROS), endothelin and 
constricting prostanoids (Komori and Vanhoutte 1990). N O w a s identified as 
the major E D R F , produced in endothelial cells, by the actions of endothelial 
nitric oxide synthase (eNOS). 
Endothelial cell functions is a measure by N O bioavailability, which in turn, is 
governed by the relative level of N O and R O S (Wilcox 2002, Bloodsworth 
2000). N O production is determined by the expression and activity of e N O S ; 
while R O S level is regulated by the balance between oxidant and antioxidant 
enzymes (SGderdahl et al. 2003, Fridovich 1995). In pathological conditions, 
where there is a over-production of R O S , N O is rapidly scavenged, resulting in 
the formation of peroxynitrite (ONOO-), a highly reactive species leading to 
lipid peroxidation, D N A damage and protein nitration (Bloodsworth et al. 2000). 
Such a net decrease in N O bioavailability can be illustrated by an impaired 
1 
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endothelium-dependent vasodilatation, and regarded as endothelial cell 
dysfunction (Ide and Node 2009, Hayashi et al. 2008). Endothelial cell 
dysfunction is likely to initiate a cascade of events in vasculature, leading to 
cardiovascular diseases, such as inflammation, hypertension and 
atherosclerosis (Moncada 1991，Wassmann 2004). 
1.2) Oxidative stress in the vascular wall 
As aforementioned, the level of R O S in vasculature is maintained in balance 
by the expressions of oxidant and antioxidant enzymes (Soderdahl et al. 2003, 
Fridovich 1995). R O S are formed by reduction of oxygen (0
2
). hydrogen 
peroxide (H202), superoxide anion (02-'). hydroxy I radicals (OH) and NO 
through metabolic processes (Cheeseman and Slater 1993，Beckman and 




•“ while the 




, either spontaneously 
or through reaction catalyzed by superoxide dismutases (Cheeseman and 
Slater 1993). 
The physiological level of R O S plays an essential role in normal cellular 




 acts as an E D H F and mediates acetylcholine 
(ACh)-induced vasodilatation in mouse small mesenteric arteries (Matoba et al. 
2000), mouse cerebral artery (Drouin et al. 2007), and rat femoral arteries 
(Leung et al. 2006). O n the contrary, in response to different risk factors, 
including hypertension and diabetics, the increased expression and/or activity 
of oxidant enzyme lead to an over-production of R O S (Droge 2002, 
W a s s m a n n et al. 2004, Mayhan et al. 2008). 
2 
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1.2.1) Sources of ROS 
R O S are generated non-enzymatically, along the electron transport chains in 
mitochondria and in the endoplasmic reticulum, to molecular oxygen, forming 
0
2
'". There are different enzymatic sources of R O S , such as xanthine oxidase, 
uncoupling o f e N O S and NAD(P)H oxidase. (Babior etal. 2002’ Vignais 2002). 
The proteolytic conversion of xanthine dehydrogenase to xanthine oxidase 






 (Yokoyama et al. 
1990). NAD(P)H oxidase mediates angiontensin II (Ang ll)-induced 0
2
»" 
production (Warnholtz et al. 1999, Chabrashvili et al. 2003) (see Fig 1.1) 
1.2.2) Actions of ROS 
R O S exert diverse cellular effects in both endothelial cells and V S M C s . In 
endothelium, the level of R O S regulates cell cycle arrest and apoptosis (Galle 
et al. 1999), monocyte adhesion (Lin et al. 2008a), and angiogenesis (Gu et al. 
2003). R O S also mediates V S M C s growth (Ahn et al. 2007, Levonen et al. 
2007), migration (Nakamura et al. 2007) and regulates the expression of 
extracellular matrix proteins (Gurjar et al. 2001). 
1.2.2.1) Impaired endothelium-dependent vasodilatation 
In pathological conditions (such as diabetes, hypertension, heart failure and 
atherosclerosis), increased oxidative stress leads to endothelial dysfunction. 
0
2
'' inactivates N O and thus forms O N O O - , resulting in a decreased N O 
bioavailability (Cai and Harrison 2000). R O S scavenger is effective in restoring 
N O bioavailability and improves the endothelial NO-mediated relaxations. For 
instance, the superoxide dismutase mimetic, tempol, restored the impaired 
vasodilatation in renal afferent arterioles of diabetic rabbits (Schnackenberg 
3 
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and Wilcox 2001). 
1.2.2.2) V S M C migration 
After injury, the artery is repaired in part by cells that migrate from adjacent 




 (Weber et al. 2004). 
Multiple sources of R O S have been implicated, including NAD(P)H oxidase 
(ten Freyhaus et al. 2006). In addition to direct regulation of migration related 
signaling, R O S also mediates V S M C migration through the induction of 
monocyte chemotactic protein-1 (MCP-1) (Lo 2005). Another important 
mechanism in V S M C migration is mediated via regulation of the breakdown of 
extracellular matrix with association of secretion of matrix metalloproteinases 
( M M P ) (Johnson and Galis 2004). In atherosclerotic plaques, R O S released by 
macrophage-derived foam cells are found to trigger activation of M M P . R O S 
increased matrix degradation in areas of high oxidative stress, thus contribute 
to instability of plaques (Rajagopalan et al. 1996). Moreover, in arterial 
hypertension, mechanical stretch would lead to vascular wall remodeling which 
involves M M P . Stretch stimulates NAD(P)H oxidase-dependent R O S formation 
and enhances the M M P - 2 expression (Grote et al. 2003), further supporting a 
positive role of R O S in vascular remodeling. 
1.2.2.3) Programmed cell death (cell apoptosis) 
Apoptosis of vascular cells is an early event in both inflammatory-mediated 
and mechanical injuries. Endothelial cells apoptosis is resulted from 
overproduction of R O S . This is considered as a mechanism that 
counterbalances cell proliferation (Bayraktutan 2005). Various stimuli trigger 
apoptosis by increasing intracellular R O S production. Warnholtz et al. (1999) 
4 
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reported that Ang II treatment increased NAD(P)H oxidase activity and 
enhanced the production of endothelial 0
2
'*, which finally elicited endothelial 
cells apoptosis. Oxidized low-density lipoprotein (LDL) also stimulates 
endothelial cells apoptosis by triggering R O S over-production via a similar 
mechanism (Galle et al. 2001). Furthermore, 0
2
«" production by the activated 
macrophages triggers a calcium-dependent inostiol trisphosphate-related 
apoptotic cascade in endothelial cells (Madesh et al. 2005). 
5 
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Figure 1.1. Under diseased states, upon stimulation by chemicals or risk 
factors (1), membrane-bound NAD(P)H oxidase is activated, and oxygen is 
metabolize to give superoxide anion (0
2
»') both outside (2a) and inside (2b) the 
endothelial cells. Enzymes present in the cytosol such as xanthine oxidase, 
cyclooxygenase and lipoxygenase are responsible for production of 0
2
»". 
Mitochondrial electron transport chains also contribute to oxidative stress in 
endothelial cells (3). Superoxide dismutase detoxifies 0
2







•‘ combines with N O derived from L-arginine by endothelial nitric oxide 
sythase to form peroxynitrite (ONOO") (5). (XO, xanthine oxidase; C O X , 
cyclooxygenase; LOX, lipooxygenase; S O D , superoxide dismutase; e N O S , 
endothelial nitric oxide synthase; O N O O " , peroxynitrite) 
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1.3) Endothelial cell apoptosis 
1.3.1) Apoptosis and cardiovascular diseases 
Elevated apoptosis is associated with pathogenesis of human diseases, such 
as failing heart (Hetts 1998), advanced and unstable atherosclerotic plaque 
(Bauriedel et al. 1999), hypertension (Okura et al. 2002) and graft 
arteriosclerosis (Moldovan et al. 1998). Recently, endothelial cells apoptosis 
has found to contribute to atherosclerosis by increasing the permeability of 
endothelial monolayer and subsequent uptake of lipids in the vessel wall (Choy 
et al. 2001). Clinical studies also suggest the contributory roles of endothelial 
cells apoptosis in plaque destabilization and thrombosis (Tricot et al. 2000). 
Moreover, the expression of phosphatidylserine (PS) is increased in 
endothelial cells apoptosis and results in a loss of anticoagulant components 
of the endothelial cells membrane, as tissue factor activity is enhanced by PS, 
which is highly thrombogenic (Mallat and Tedgui 2000). Taken together, with 
the emerging role of endothelial cells apoptosis in a triggering and mediating 
pathogenesis of vascular diseases, a better understanding of the mechanisms 
of endothelial cells apoptosis will provide clues for novel therapeutic targets in 
a wide range of vascular events. 
1.3.2) Mechanisms of endothelial cells apoptosis 
Apoptosis is resulted from extracellular stimulations which cause activation of 
a cluster of cysteine proteases (caspases). Caspases then mediate selective 
cleavage of cellular components, including D N A and cytoskeleton (Wen et al. 
1997，Brancolini et al. 1997). Apoptotic cells shrink and can be recognized by 
the presence of a condensed chromatin (Kerr 1972). The cell membrane forms 
blebs and vesicles; finally, nuclear fragmentation and formation of dense 
7 
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apoptotic bodies are resulted (Wyllie 1980, Coleman et al. 2001). Membrane 
vesicles released from endothelial cells exposed to peroxide are shown to 
contain oxidized phospholipids and activate neutrophils (Patel et al. 1992). 
Moreover, increased levels of membrane vesicles have been found in patients 
with acute coronary syndrome (Mallat et al. 2000), diabetes mellitus (Nomura 
et al. 1995), and in h u m a n artherosclerotic plaque (Mallat et al. 1999). 
1.3.2.1) W h a t are caspases? 
Caspases belong to a family of cysteine-dependent aspartate-specific acid 
proteases that cleave target proteins at aspartic acid residues (Alnemri et al. 
1996). Based on the structure of the domain and functions, caspase gene 
family consists of 15 mammalian members (Alnemri et al. 1996, Deveraux and 
Reed 1999). A m o n g all, caspase-3 knockout mice pinpointed a central role of 
caspase-3 in mammalian cell apoptosis (Kuida et al. 1996). Caspase-8 and -9 
mediated activations were subsequently identified to be involved in 
caspase-3-dependent signaling pathways (Boldin et al. 1996，Muzio et al. 1996, 
Li et al. 1997, Luo et al. 1998). Caspases inactivate proteins that protect the 
cells from apoptosis. For example, caspase-3 cleaves anti-apoptotic Bcl-2 
proteins (Xue and Horvitz 1997，Cheng et al. 1997，Adams and Cory 1998). 
Moreover, caspases also directly disassemble cell structure as shown by the 
destruction of nuclear lamina, which is the rigid structure underlying the 
nuclear m e m b r a n e and is involved in chromatin organization (Takahashi et al. 
1996, Orth et al. 1996). O n the other hand, caspases can be activated to from 
a cleaved caspase, which subsequently mediates the downstream signaling 
cascade leading to cell apoptosis. These signaling cascades include the 
shutdown the D N A repair and replication systems, cutting off contact with 
8 
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surrounding cells as well as the disintegration of the cell into apoptotic bodies. 
There are two major signaling pathways for the activation of caspase-3 in 
cell apoptosis (see Fig 1.2), the extrinsic pathway involving membrane-bound 
death receptors of the tumor necrosis factor-receptor (TNF-R) family (Schmitz, 
Kirchhoff and Krammer) and the intrinsic pathway depending upon the release 
of cytochrome c from mitochondria (Li et al. 1998b, Ahn et al. 2007). 
1.3.2.2) Death receptor-mediated apoptosis 
The apoptotic pathway can be activated by ligand-bound death receptors of 
the T N F family, such as Fas, T N F R 1 or the TRAIL receptors D R 4 and DR5. 
Binding of ligands to their respective receptors triggers receptor aggregation 
and subsequent recruitment of adaptor protein, Fas Associated Death Domain 
(FADD) consisting of two protein domains: a death domain and a death 
effector domain (DED) (Chinnaiyan et al. 1995). F A D D binds to the death 
domain of the receptor and receptor-interacting protein, followed by recruiting 
caspase-8, leading to caspase-8 activation (Muzio et al. 1996). Eventually, 
effector caspase-3, -6 and -7 are activated and then elicit the onset of 
apoptosis (Degterev 2003). O n the other hand, the pro-apoptotic protein, Bid, 
is cleaved by caspase-8 and then translocated to the mitochondria, activating 
the intrinsic cascade (Luo et al. 1998), thus connecting the two pathways 
together and amplifying the effect of the death receptor signaling pathway. 
1.3.2.3) Mitochondria-dependent pathway 
The intrinsic pathway depends on the release of cytochrome c from 
mitochondria into the cytoplasm, caused by apoptotic stimuli, such as cytoxic 
stress, oxidative stress, heat shock, and D N A d a m a g e (Fan 2001, Finkel 
9 
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2001a). Cytochrome c associates with apoptotic protease-activating factor-1 
(Apaf-1) and procaspase-9. The cytochrome c and Apaf-1 complex could 
activate caspase-9 and hence activate the downstream effector caspases. The 
release of cytochrome c is regulated by the relative expression and activity of 
Bcl-2 family proteins (see Fg 1.2). As mentioned before, there is a cross link 
between two parallel pathways, as the cleavage of the Bcl-2 family member 
Bid by caspase-8 involving the TNF - a signaling mechanism (Li et al. 1998b) 
results in the activation of the mitochondria-dependent apoptotic pathway. 
1.3.3) Regulations of endothelial cells apoptosis 
Apoptosis is highly regulated and initiated by either an absence of survival 
factors or a presence of pro-apoptotic factors. Apart from the oxidative stress 
mentioned, factors regulating endothelial cell apoptosis include shear stress, 
growth factors and N O . 
1.3.3.1) Oxidative stress 
Exposure of endothelial cells to oxidative stress induces apoptosis. An early in 
vitro study showed that endothelial cells exposed to menadine sodium bisulfite, 
which can be metabolized to release 0
2
-" caused an elevated level of 




 is also shown to trigger 
endothelial cells apoptosis via the mitochondria-dependent pathway (Lu et al. 
2007). These studies reveal a key role of R O S in endothelial cells apoptosis. 
Platelets, neutrophils, monocytes, lymphocytes and erythrocytes are the major 
source of extracellular 0
2
•“ (Abdu et al. 2001), while the major source of 
endogenous 0
2
•“ is NAD(P)H oxidase, which is known to be overexpressed in 
atherosclerotic and diabetic vasculatures (Griendling 2000). Ang II is a potent 
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enhancer for NAD(P)H oxidase activity via Ang II type I receptor (Dimmeler et 
al. 1997c) and promotes oxidative stress-induced endothelial dysfunction and 
apoptosis (Schmidt-Ott 2000). Besides, oxygen radicals formed in the vessel 
wall oxidizes LDL. Upon binding to LOX-1 receptor, oxidized LDL stimulates 
apoptosis via both extrinsic and intrinsic pathways, inducing the degradation of 
the pro-survivial proteins, Akt (Li and Mehta 2009, Napoli et al. 2000, Aviram 
2000, Rusinol et al. 2004). Oxidized LDL can also induce macrophage death 
through the mitochondrial pathway (Salvayre et al. 2002, Asmis and Begley 
2003, Yao and Tabas 2001). 
1.3.3.2) Shear Stress 
Exposure to laminar shear stress reinforces endothelial cells contacts, with a 
subsequent increase in survival signals (Urbich et al. 2000). It up-regulates the 
expression of anti-apoptosis markers (Bartling et al. 2000) and enhances the 
expression of e N O S (Napoli and Ignarro 2001). Certain areas of the artery, 
including branch points where there is a relative lower shear stress or 
disturbed flow, are more susceptible of endothelial cells apoptosis (Levkau et 
al. 1998). Endothelial cells exposed to disturbed flow promote apoptosis 
through reduction of Akt expression, and stimulate monocyte adhesion via a 
ROS-dependent manner (Chappell 1998, Dardik et al. 2005). Moreover, 
membrane vesicles and apoptotic blebs isolated from endothelial cells 
undergoing apoptosis are shown to induce monocyte adhesion by 
up-regulating connecting segment-1 (CS-1) fibronectin and vascular cell 
adhesion molecule-1 (VCAM-1) on the endothelial cells surface (Chappell 
1998, Cole et al. 2003), thus leading to vascular inflammation and 
atherosclerosis. 
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1.3.3.3) Growth factors 
The absence of growth factors induces apoptosis in both V S M C s and 
endothelial cells (Stoneman and Bennett 2004). Vascular endothelial growth 
factor (VEGF), angiopoietin-1 and basic fibroblast growth factor-2 (bFGF-2) 
are s o m e of the growth factors found in endothelial cells. V E G F up-regulates 
anti-apoptotic protein Bcl-2 (Gerber 1998) and the expression of inhibitor of 
apoptosis proteins (lAPs) (Liu et al. 2000); bFGF-2 inhibits serum 
deprivation-induced endothelial cells apoptosis (Karsan et al. 1997). Moreover, 
angiopoietin-1 has been shown to bind to endothelial cell-specific tyrosine 
kinase receptor to promote endothelial cells survival (Fujikawa et al. 1999). 
1.3.3.4) N O 
N O produced by N O synthase (NOS) is an important regulator of endothelial 
cells apoptosis. Physiological level of N O formed from e N O S protects 
endothelial cells from apoptosis in cyclic GMP-dependent and -independent 
pathways as activation of cyclic GMP-dependent protein kinases is associated 
with an anti-apoptotic effect (Polte 1997). N O also protects endothelial cells by 
inhibiting the activation of caspase-3 (Dimmeler et al. 1997b, Kim 1999). The 
beneficial effects of L-arginine in h u m a n studies have further confirmed the 
importance of the anti-atherogenic effects of N O (Napoli and Ignarro 2003, de 
Nigris et al. 2003). Moreover, anti-apoptotic pathway induced by shear stress 
involves the phosphorylation of Akt/protein kinase B (PKB), release of N O and 
inhibition of caspase-3 (Dimmeler et al. 1998，Dimmeler et al. 1999). 
However, another isoform of N O S , inducible N O S (iNOS) is highly 
expressed in atherosclerotic plaque. N O produced by iNOS in macrophages 
induce large amount of reactive nitrogen species by reacting with superoxide 
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anions and promote oxidative damage (Buttery et al. 1996), which then cause 
release of cytochrome c. Moreover, incubation of endothelial cells with high 
levels of N O stimulates apoptosis, accompany with a reduced level of Bcl-2 
and increased level of Bax, a pro-apoptotic protein (Patel et al. 2000). 
1.3.3.5) Inflammatory mediators 
Apoptosis can be induced by the presence of extra- or intracellular molecules 
by inhibiting the survival pathways or switching towards the pro-apoptotic 
pathway. H u m a n umbilical vein endothelial cells (HUVECs) exposed to tumor 
necrosis factor-a (TNF-a) results in degradation of anti-apoptotic protein, Bcl-2 
and activation of caspase-3 (Dimmeler et al. 1996). Peripheral blood 
mononuclear monocytes (PBMCs) activated by bacterial lipopolysaccharide 
(LPS) induces apoptosis in cultured endothelial cells (Lindner et al. 1997). This 
process was shown to depend on TNF - a . Addition of anti-inflammatory 
cytokine IL-10 attenuated the LPS-induced P B M C s apoptosis (Haendeler 
1996). O n the other hand, another pro-inflammatory marker, oxidized LDL, 
also plays a significant role in atherogenesis as it was detected in human 
atherosclerotic lesions (Napoli et al. 1997, Napoli et al. 1999a, Napoli et al. 
1999b). Several studies already show that oxidized LDL exhibits cytotoxic 
effect on endothelial cells. Exposure of bovine aortic endothelial cells to 
oxidized LDL increases apoptotic cell death (Lizard et al. 1996). Oxidized LDL 
is also known to release R O S , thereby eliciting the apoptotic process in 
various cell types. Addition of antioxidants such as vitamins C and E can 
completely inhibit the activation of caspase-3 by oxidized LDL (Dimmeler et al. 
1997a). 
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Figure 1.2. Upon binding of Fas-L to Fas, Fas associated death domain is 
recruited and procaspase-8 is activated (1). Active caspase-8 then directly 
activates the downstream effector caspases (3，6 and 7) (2a), or via 
caspase-9-dependent pathway (2b), resulting in D N A fragmentation and 
cleavage of cellular proteins, leading to apoptosis. In addition, upon non-death 
receptor stimulation, such as growth factor withdrawal or activation of p53 (3), 
mitochondrial pathway also stimulated to induce apoptosis, release of 
cytochrome c after activation of Bax and Bid from mitochondria (4). 
Association between cytochrome c and apoptotic protease-activating factor-1 
leads to activation of caspase-9 (5). And eventually, activates the effector 
caspases (6). (ECs, endothelial cells; FADD, Fas associated death domain; cyt 
c, cytochrome c; Apaf-1, apoptotic protease-activating factor-1) 
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1.4) Mitogen activated kinases signaling in apoptosis 
Since cells are always exposed to a variety of environmental stress, signaling 
pathways responding to stress is very crucial for the maintenance of normal 
cellular function. A m o n g all pathways, mitogen-activated protein kinases 
(MAPKs) family members play the most important role in regulating the cell 
function. Three subfamilies of M A P K s have been identified, including 
extracellular signal-regulated kinases (ERK), c-Jun N-terminal kinases (JNK) 
and p38 M A P K (Tibbies and Woodgett 1999, Widmann et al. 1999, Davis 2000, 
Chang and Karin 2001, Johnson and Lapadat 2002). E R K is a well-known 
target of growth stimuli. Both J N K and p38 M A P K are activated in response to 
various cellular and environmental stress, such as osmolarity or metabolism, 
D N A damage, heat shock, ischemia, inflammatory cytokines, ultra-violet 
irradiation ceramide or oxidative stress (Tibbies and Woodgett 1999’ Widmann 
et al. 1999, Davis 2000, Chang and Karin 2001, Johnson and Lapadat 2002, 
Dent et al. 2003). 
R O S plays a central role in many cellular responses, including the 
regulation of M A P K s . It has been reported that norepinephrine (NE)-induced 
endothelial cells apoptosis through R O S - J N K activation pathway (Fu et al. 





 induced cell apoptosis is regulated by a balance of death signaling p38 
and J N K and the survival signaling, including E R K and PI3K-Akt pathways (Xia 
et al. 1995). Besides, T N F - a stimulates the ceramide signaling, in which 
ceramide serve as an upstream activator for M A P K s signaling (Zhang et al. 
2006). Co-activation of J N K and p38 M A P K induces apoptosis in cardiac cells 
(Feuerstein and Young 2000). In rat pheochromocytoma cells, removal of 
nerve growth factors shows sustained activations of J N K and p38 M A P K , while 
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inhibition of E R K leads to cell apoptosis (Xia et al. 1995). This suggests that 
E R K is a survival factors while the others are pro-apoptotic. 
The role of different M A P K s in the physiological responses of cells to 
various stimuli can be demonstrated by using their specific inhibitors. Two 
inhibitors were developed for E R K . P D 98059 and U0126 were characterized 
as inhibitors of both M E K 1 and 2, which are upstream to E R K (Favata et al. 
1998). Therefore, both serve to inhibit E R K activation. S B 202190 and S B 
203580 were used to inhibit the p38 M A P K activity. For instance, S B 203580 
was proven to block the activation of M A P K A P kinase-2, direct substrate of 
p38 in response to various cytokine stimulations (Cuenda et al. 1995). 
Administration of S B 203580 in rat before the ischemic insult markedly 
inhibited the p38 M A P K activity and diminished the ischemia/reperfusion injury, 
including apoptosis (Ma et al. 1999). S P 600125 is widely used to inhibit the 
J N K activity and hence blocked the N E induced endothelial cells apoptosis (Fu 
et al. 2006). Use of these specific inhibitors helps to elucidate the role of 
M A P K s in different cellular responses. 
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1.5) Bone morphogenic proteins (BMPs) 
The negative effect of bone morphogenic protein (BMP)-4, a novel 
pro-inflammatory factor, on vascular endothelial cell function has been recently 
demonstrated (Sorescu et al. 2003). B M P s are secreted as a precursor and 
the mature proteins are formed from proteolytical cleavage (Wozney et al. 
1990). Several inflammatory factors, such as VCAM-1, ICAM-1 were induced 
through the production of B M P 4 in vascular endothelial cells (Sorescu et al. 
2003, Jo 2006) and transforming growth factor p (TGFp) in valvular endothelial 
cells (Sucosky et al. 2009). Although B M P was first discovered as a bone 
growth factor (Li and Wozney 2001), it has recently suggested that B M P 4 is 
involved in endothelium-mediated vascular inflammation and found to be a 
shear-sensitive gene in cultured endothelial cells (Sorescu et al. 2003). 
1.5.1) BMPs functions and cardiovascular system 
B M P s belong to the T G F p superfamily of growth factors (Shi and Massague 
2003). T G F p family members have critical and specific roles during 
embryogenesis and maintaining the homeostasis of tissues. They elicit the 
cellular effects by binding to a complex of type II and type I serine/theronine 
kinase transmembrane receptor. There are five type II receptors and seven 
type I receptors found in m a m m a l s (Heldin 1997, Shi and Massague 2003, 
Schmierer and Hill 2007). Several isoforms of B M P s , including BMP-2, -4, -6, 
-7 and -9 are discovered. They regulate cell growth (Ebendal 1998), 
differentiation (Wozney and Rosen 1998), and cell death (Kiyono and Shibuya 
2003). They also exhibit various actions on the cardiovascular system. B M P 4 
was shown to induce proliferation and migration of endothelial cells through 
stimulation of V E G F - A and Tie-2 signaling (Suzuki et al. 2008). B M P 6 
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promotes endothelial cells migration and tube formation via S m a d 1/5/8 
phosphorylation (Valdimarsdottir et al. 2002). B M P 9 has been recently 
reported to be a circulating vascular quiescence factor by acting on the type I 
receptor (David et al. 2008). Moreover, in vivo B M P s are found to induce tumor 
angiogenesis (Langenfeld and Langenfeld 2004). B M P s also play a role in 
vascular S M C differentiation and function. B M P 2 was demonstrated to 
stimulate V S M C migration; however, it prevented platelet-derived growth 
factor 一 induced V S M C proliferation through induction of the PPARy/apoE 
pathway (Hansmann et al. 2008，Willette et al. 1999). In pulmonary S M C , 
B M P 4 and B M P 7 induce apoptosis via caspase-8 and caspase-9 dependent 
mechanisms (Lagna et al. 2006). Mutations in the B M P type II receptor gene 
cause familial pulmonary arterial hypertension, a condition characterized by 
excessive soomth muscle cells and endothelial cells proliferation (Lane et al. 
2000, Machado et al. 2006). BMPRII signaling was found to be essential for 
BMP-mediated regulation of V S M C growth and differentiation (Yu et al. 2008). 
1.5.2) BMPs signaling pathways 
1.5.2.1) Smad-dependent pathway 
Like other members of the T G F p family, B M P signaling is mediated through the 
activation by combination of type I and type II serine/threonine kinase 
receptors (Miyazono 2005). The receptors then signal via the activation of the 
traditional T G F p signaling proteins called S m a d proteins (see Fig 1.3). Upon 
activation of the receptor, receptor-regulated S m a d (R-Smads) protein would 
be recruited and phosphorylated. R-Smad 1/5/8 was found to be involved in 
the B M P s signaling. Furthermore, the activated R-Smads forms complex with 
the c o m m o n mediator S m a d 4 and translocates into nucleus, where they 
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regulate the transcription of specific target genes by working with other 
proteins. Regarding the inhibitory S m a d s (l-Smad), S m a d 6 and 7, they can 
inhibit the activation of R-Smads by competing with R - S m a d for type I receptor 
interaction and by recruiting specific ubiquitin ligases or phosphotases to the 
activated complex, hence, targeting them to proteosomal degradation or 
dephosphorylation (Heldin et al. 1997, Shi and Massague 2003, Schmierer 
and Hill 2007). 
1.5.2.2) M A P K s and S A P K s pathways 
O n the other hand, B M P s are also found to activate M A P K s pathways such as 
p38 and ERK1/2 as well as stress activated protein kinases (SAPK) including 
c-Jun N-terminal kinases (Miyazono 2001). B M P 4 induced h e m e oxygenase-1 
in a S m a d independent, p38 M A P K dependent pathway in pulmonary arterial 
myocytes (Yang et al. 2007). It is also reported that B M P 4 exhibit its 
synergistic effect with Wnt3a on differentiating mouse embryonic stem cells 
through PI3K, p38 M A P K , ERK1/2 and J N K pathways (Lin et al. 2008b). In 
colon cancer cells, B M P 4 can protect them from heat-induced apoptosis 
through enhancing the activation of E R K as well as inhibiting the activation of 
J N K (Deng 2007). Both B M P 2 and 4 are demonstrated to promote the 
monocyte adhesion in P K C / M A P kinase-dependent pathway in H C A E C s 
(Csiszar et al. 2006). In the presence of IL-6, B M P 2 induced apoptosis in 
mouse hybridoma M H 6 0 cells through TAK1 p38 M A P K pathway. Furthermore, 
activation of p38 M A P K is involved in BMP2-induced neuronal differentiation in 
P C 1 2 cells (Iwasaki et al. 1999). Nohe et al has reported that activation of 
S m a d or M A P K s is dependent on the m o d e of the receptor interaction (Nohe et 
al. 2002). Importantly, existing evidence revealed that B M P s exhibit their 
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biological effects not only through S m a d pathways, but also via M A P K and 
S A P K signaling pathways in different cells. 
1.5.2.3) Antagonists of B M P s signaling 
The biological responses of B M P s are highly depending on its concentration. 
The presence of antagonists is important for regulating the level of BMPs, 
there are many antagonists known to bind to specific B M P s , including noggin, 
chordin, crossveinless-2 (CV-2), follistatin, gremlin and twisted gastrulation 
(Tsg) (Balemans and Van Hul 2002). They act to inhibit the interaction of B M P s 
to their respective receptors. Noggin and chordin bind directly with B M P 2 and 
B M P 4 and thus prevent them from bind to the receptor. Experimentally, the 
B M P actions can be confirmed by using their cognate antagonists; for example, 
B M P 4 action can be blocked by noggin. 
1.5.3) BMP4 and cardiovascular diseases 
B M P 4 and its closely related protein, B M P 2 , are up-regulated in calcified 
atherosclerotic plaque and aortic valvular diseases (Dhore et al. 2001, 
Bostrom et al. 1993, Mohler et al. 2001). Atherosclerosis is shown to be 
preferentially developed in the regions of branched and curved arteries. Within 
these regions, the vascular endothelial cells are exposed to disturbed flow 
conditions, including oscillatory shear stress. In response to these stimuli, 
adherence, migration and accumulation of monocytes and T-cells occurred 
(Ross 1999). However, there is relatively low incidence for the straight portions 
of the artery exposed to undisturbed laminar shear stress to develop 
inflammation (Dai et al. 2004, Davies et al. 2001, Traub and Berk 1998). Many 
research groups show that mechanisms of prevention and initiation of 
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inflammation are likely to be mediated by the responses of endothelial cells to 
the flow conditions (Traub and Berk 1998, Davies 2009). B M P 4 w a s known as 
a mechanosensitive cytokine mediating the response to inflammation and 
oscillatory shear stress in endothelial cells (Sorescu et al. 2003). Oscillatory 
shear stress stimulated adhesion of endothelial V A C M - 1 and ICAM-1 in B M P 4 
dependent pathway. Furthermore, B M P 4 impairs vasorelaxation mediated 
through the production of R O S by activation of N A D P H oxidase in mouse 
aortas, which could decrease endothelial N O bioavailability and leads to 
hypertension (Miriyala et al. 2006). These findings suggests a crucial role of 
B M P 4 in mediating the pro-inflammatory and pro-atherogenic responses of 
oscillatory shear stress, through R O S released from NAD(P)H oxidase in 
endothelial cells. Elucidation of B M P 4 signaling cascades shall help better 
understanding of the role of oscillatory shear stress in vascular biology and 
also in the development of therapeutics approaches for atherosclerosis. 
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Figure 1.3. B M P s signaling pathways. B M P s bind to a complex of type I and II 
B M P receptor. S m a d 1/5/8 are activated by phosphorylation, which 
translocates to the nucleus as trimeric complex with C o - S m a d 4. T h e complex 
interacts with other transcription factors. Other pathways including 
M A P K / S A P K are also involved in B M P s signaling, leading to different cellular 
responses. ( B M P 1 R and B M P 2 R , type I and type II bone morphogenic protein 
receptor; TF, transcription factors; M A P K , mitogen-activated protein kinases; 
S A P K , stress-activated protein kinase) 
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1.6) Justification, long-term significance and objectives of the 
present project 
Since endothelial cells apoptosis is a crucial process in the development of 
inflammatory diseases including atherosclerosis and hypertension, and B M P 4 
is recently proven to be upregulated in endothelial cells by oscillatory shear 
stress. Based on the important role of B M P 4 in the formation in atherosclerotic 
plaque, the present study aimed to elucidate the underlying mechanism 
underlying BMP4-induced endothelial cells apoptosis by using primary 
cultured rat endothelial cell (RAEC) and human vein endothelial cells ( H U V E C ) 
as a model and to test the involvement of M A P kinases and S A P kinases as 
well as the role of R O S in the BMP4-induced apoptotic pathway with use of 
various pharmacological agents. The results from the present study shall 
provide novel evidence in support of the potential damaging effect of B M P 4 , a 
novel pro-inflammatory, on endothelial cell function and its potential as a 
therapeutic target. 
The objectives of the present project were therefore to investigate: 
1. whether or not B M P 4 induces endothelial cells apoptosis via a caspase-3 
dependent pathway 
2. whether or not R O S released form NAD(P)H oxidase mediates 
BMP4-induced endothelial cells apoptosis 
3. whether or not M A P K and S A P K in BMP4-induced endothelial cells 
apoptotic pathway 
In order to achieve the above-stated objectives, a combination of experimental 
approaches w a s employed in the present study and they included molecular 
biology methods, biochemical assays, imaging, and staining techniques. 
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CHAPTER II 
Methods and Materials 
2.1) Animal handling 
The study was approved by the Animal Experimentation Ethics Committee, 
The Chinese University of Hong Kong (CUHK). Rats were supplied by the 
C U H K Laboratory Animal Service Center and housed at room temperature 
(25°C) with alternating 12-h light / 12-h dark cycle and fed on standard rat 
chow and water ad libitum. 
2.2) Endothelial cell isolation and culture 
2.2.1) Primary culture of rat endothelial cells 
Primary aortic endothelial cells were isolated and cultured using a protocol 
described previously (Pearson et al, 1978; Kwan et al., 2000; Leung et al., 
2006). Briefly, adult male Sprague-Dawley rats (three-month old, body weight 
of about 260-280 g) were sacrificed by C 0
2
 suffocation. The thoracic aorta was 
dissected out, cleaned of surrounding connective tissues, and washed twice in 
sterile phosphate buffer saline (PBS). Isolated aortas were then cut open 
longitudinally and digested with 0.2% type 1A collagenase (Sigma-Aldrich) in 
P B S in a shaking water bath at 37°C for 15 minutes. The mixture was 
centrifuged at 800 x g for 5 minutes and supernatant was removed. Cells were 
re-suspended in R P M I medium 1640 (GIBCO) containing 1 0 % fetal bovine 
serum (FBS), 100 U/ml penicillin and 100 jig/ml streptomycin (P/S) (GIBCO). 
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Cells were settled in a 75 c m
2
 flask and incubated at 37°C in an atmosphere of 
9 5 % / 5 % humidified air / C 0
2
 atmosphere for 1 hour. Medium was changed 
every three days. Confluent cells were passaged by treating with trypsin 
(0.25%) in 2.5 m M E D T A . To avoid possible impact of the culture condition on 
endothelial cell properties, only cells of the first two passages and those 
maintained in the same culture condition for less than one week were used for 
the experiments. 
2.2.2) Culture of human umbilical cord vein endothelial cells 
H u m a n umbilical cord vein endothelial cells (HUVECs) obtained from Lonza 
(CC-3317) were grown in endothelial growth medium (EGM, Clonetics) 
supplemented with brain barrier extract (BBE, Clonetics) and 1 % penicillin and 
streptomycin (GIBCO). Cells were grown in 75 c m
2
 flasks and maintained at 37 
°C in a 9 5 % / 5 % humidified air / C 0
2
 atmosphere. Medium was changed 
every two days. Confluent cells were passaged by treating with trypsin (0.25%) 
in 2.5 m M E D T A . Experiments were performed on cells at passage 4 - 6 when 
80 一 9 0 % confluency was achieved. 
2.3) Apoptosis assessment 
2.3.1) Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling 
(TUNEL) assay 
T U N EL assay was used to detect D N A fragmentation in situ. The detection 
procedures were in accordance with instructions provided in the ApopTag 
Peroxidase In Situ Apoptosis Detection Kit S7100 (Chemicon International A 
Serologicals Company). Briefly, cells were seeded onto coverslips. After drugs 
treatment, cells were fixed in 4 % paraformaldehyde in P B S (pH=7.4) at 4 °C 
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overnight. Thereafter, they were washed in P B S for 5 minutes. For adherent 
cells, freshly diluted proteinase K digestion (20 |jg/ml) was applied onto the 
cells at room temperature for 10-15 min followed by two washes in 
double-distilled H
2
0 . The endogenous peroxidase reaction was first quenched 
in P B S containing 3 % hydrogen peroxide for 5 minutes at room temperature 
and the specimen was rinsed twice in P B S for 5 minutes each time; then, 
specimen was incubated with equilibration buffer for 10 seconds at room 
temperature. Freshly prepared working strength TdT enzyme was added to the 
specimen for 1 hour in a humidified chamber at 37°C. The specimen was put in 
a coplin jar containing working strength stop/wash buffer, agitated for 15 
seconds and incubated for 10 minutes. Subsequently, the specimen was 
washed for 3 times in PBS, 1 minute for each wash. Sample was then 
incubated with anti-digoxignenin conjugate for 30 minutes at room temperature. 
Staining was visualized as brown precipitate by using 3, 3，-diamonobenzidine 
tetrachloride (DAB) chromogen substrate (Vector laboratory). D A B was added 
and incubated for 5 minutes. Slides were rinsed in water and counterstained by 
hematoxylin, immersed in acid alcohol to remove the excess haematoxylin and 
washed in tap water. Finally, slides were immersed into Scott tap water to 
make the nucleus appearing blue. Slides were mounted with Gel/Mount (Dako 
Ultramount Aqueous Permanent Mounting Medium) for pictures to be taken 
under a Leica D M R B E microscope equipped with software Spot Advanced. 
Apoptotic cells were counted as cells having condensed and fragmented 
nucleus. Summarized data was expressed as the percentage of apoptotic cells 
measured in each experiment. 
2.3.2) Cell death detection ELISA kit 
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Cell death detection ELISA (Roche) was performed according to the 
manufacturer's instruction. Briefly, 1 x 10
4
 cells were seeded in microplate 
wells. After treatment, cells were lysed with Lysis Buffer and incubated for 30 
minutes at room temperature. Lysate was then centrifuged at 200 x g for 10 
minutes. After centrifugation, 20 pi of the supernatant was transferred to the 
streptavidin coated microplate. 80 [j| of fleshly prepared immunoreagent was 
added to each well. The plate was covered with adhesive foil and gently 
shaked at 300 rpm for 2 hours at room temperature. After solution in the wells 
was removed thoroughly and carefully, A B T S solution was added. The 
mirocplate was incubated on a plate shaker at 250 rpm for 10 minutes so that 
color development was sufficient for photometric analysis. After incubation, 
samples were stopped by A B T S stop solution and optical density was read 
using an ELISA reader at 405 nm. Summarized data obtained was expressed 
as fold change of absorbance compared to control after subtracting the blank 
measurement. 
2.3.3) Flow cytometry 
For analyses of cell apoptosis, apoptotic rate was measured by propidium 
iodide (PI) and annexin-V FITC staining with flow cytometry according to the 
manufacturer's instruction (BD pharmingen). Briefly, following drug treatments, 
cells were trypsinized with trypsin (0.25%) in 2.5 m M E D T A , collected by 
centrifugation at 800 x g for 10 minutes and washed twice in cold sterile PBS. 
The cells were re-suspended in 1X binding buffer at concentration of 1 x 10
6 
cells/ml. 100 jjI (1 x 10
5
 cells) of solution was transferred to a 5 ml culture tube 
and incubated in 5 pi PI and 5 pi Annexin-V FITC for 15 minutes at room 
temperature. 400 (j丨 1x binding buffer was added and samples were analyzed 
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by flow cytometer (B&D FACSort). The instrument was set to collect 1 X 10
5 
cells and the profile was analysed using WinMDI software (version 2.8). In the 
population of cells was obtained, cells undergoing apoptosis showed stain 
positive for annexin-V FITC while negative for PI. 
2.4) Western blot analysis 
2.4.1) Sample preparation 
After treatment, cells were collected for treatment with trypsin (0.25%) in 2.5 
m M E D T A . Trypsin action was stopped by adding R P M I medium containing 
10% F B S and 1 % P/S. The mixture was centrifuged at 800 x g for 10 minutes 
and washed once in sterile PBS. After centrifugation, supernatant was 
removed and discarded. Cells pellets were subsequently homogenized in 
ice-cold RlPA lysis buffer that contained 1 |JM leupetin, 5 (JM aprotonin, 100 [jM 
phenylmethylsulfonyl fluoride, 1 m M sodium orthovanadate, 1 m M E G T A , 1 
m M EDTA, 1 m M sodium fluoride, and 2 mg/ml p-glycerolphosphate. The 
lysates were incubated for 30 minutes on ice and then centrifuged for 20 
minutes at 20,000 g. Supernatant was collected and analyzed for protein 
concentration using the Lowry method (Bio-rad, Hercules, C A , USA). 
2.4.2) SDS-PAGE and transfer 
Sample buffer containing 5 % (3-mercaptoethanol was added to the sample, 
then denatured by boiling for 10 minutes. For each sample, 20 fjg of protein 
was separated with 12.5% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE), together with the prestained and biotinylated 
size marker. The resolved proteins were then electrophorectically transferred 
to a nitrocellulose immobilon-P polyvinylidene difluoride (PVDF) membrane 
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(Millipore, Billerica, M A , USA) using a mini-trans-blot cell (Bio-rad) at 110V for 
70 minutes at 4°C. The membranes were blocked with 1 % bovine serum 
albumin dissolved in phosphate buffer saline 0.5 % tween-20 (PBST) for 1hr at 
room temperature. Primary antibodies against target proteins (information 
summarized in Section 2.6.3) were incubated in 4oC overnight, while the 
corresponding secondary antibodies conjugated to horseradish peroxidase 
(DakoCytomation) were used at a dilution of 1:3000 and incubated for 1hr at 
room temperature. The membranes were developed with enhanced 
chemiluminescence detection solutions (ECL reagents; Amersham Pharmacia, 
Pittsburgh, PA, U S A ) and exposed on X-ray films (Fuji). A documentation 
program (Flurochem, Alpha Innotech Corp.) was used to perform the 
densitometry, p-actin was selected as housekeeping protein for checking equal 
loading of the samples. Summarized data were obtained from 4-5 separated 
experiments. 
2.5) DHE fluorescence 
Cells were first seeded onto coverslips. After treatment, cells were washed 
with P B S once. The specimens were then incubated with 5juM dihydroethidium 
(Invitrogen) in P B S at 37°C in a light-protected chamber for 30 min. Slides 
were rinsed with P B S to remove excess D H E . Confocal microscopy (Olympus 
Fluoview) was applied to visualize the superoxide anions level. Settings for 
laser scan imaging included 1024 x 1024 pixel resolution; objective, x40 N A 
0.9; ethidium bromide (EtBr) excitation, 515 nm; EtBr emission, 610 n m 
band-pass filter. A field of view with 317.13 jum x 317.13 |im from each 
specimen was imaged. Data analysis was performed off-line and the D H E 
fluorescent intensity was quantified by the Fluoview program (version 1.5; 
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FV10-ASW1.5). A square region with an area of 80 (jm x 80 |jm was selected 
for analysis. Summarized data was expressed as compared with control, to 
indicate the fold change in intensity levels relative to the solvent treatment as 
negative control (Symons et al. 2006). 
2.6) Drugs, chemicals and other reagents 
2.6.1) Drugs and chemicals used in the present experiments 
Stock drug solutions were kept at -20°C. 
Chemicals Description Solvent Source 
B M P 4 Pro-inflammatory protein 0.1%
 1
BSAin Sigma 
4 m M HCI 
Noggin Protein neutralizing B M P 4 Sterile P B S Sigma 
action 




(DETCA) dismutase (Cu/Zn-SOD) 
inhibitor 




S B 202190 p38 M A P K inhibitor D M S O Tocris 
S P 600125 J N K inhibitor D M S O Tocris 
P D 98059 E R K inhibitor D M S O Tocris 
1
B S A indicate bovine serum albumin. 
2.6.2) Reagents for Western blot analysis 
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1) Reagents for sample preparation 
1.1) RIPA buffer 
K C |
 0.2 m M 
" ^ 2 P 0 4
 1 4 4 m M 
^ H 2 P 0 4
 0 2 4 m M 
NP-40 





 a 5 % 
1.2) Protease inhibitors 
TpTotonin
 5 
1 m M 
"^ TA 1mM 
p-glycerolphosphate 1 m M 
T e ^ 1 _ L 
Phenylmethylsufonyl fluoride (PMSF)
 1 m M 
Sodium fluoride
 1 m M 
Sodium orthovanadate
 1 m M 
2) Reagents for gel preparation (stacking and separating) 
30 % acrylamide Made up to 100 mL 
Methylene bis-acrylamide
 0 8 g 
Acrylamide
 2 9 2 g 
1.5 M Lower Tris-base buffer (pH 8.8) Made up to 100 mL 
" ^ b a s e I 18-1?g 
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10% S D S 4 m L 
0.5 M Upper Tris-base buffer (pH 6.8) Made up to 100 m L 
Tris-base 6.047 g 
1 0 % S D S 4 m L 
Others 
Tetramethylethylene diamide (TEMED) 2 % in final solution 
A m m o n i u m persulphate (freshly prepared) 0.1% in final solution 
3) Buffers for electrophoresis, transfer and washing 
3.1) SDS gel loading buffer (2x) 
Tris (from 1 M Tris-HCI, pH 6.8) 125 m M 
S D S 4 % 
Glycerol 2 0 % 
Bromophenol blue 0.06% 
p-mercaptoethanol 1 0 % freshly add 
3.2) Electrophoresis running buffer Adjust pH to 8.3 
Tris 25 m M 
Glycine 250 m M 
S D S 0.1% 
3.3) Transfer buffer 
Tris base 48 m M 
Glycine 39 m M 
S D S 0.037% 
Methanol 2 0 % 
3.4) PBST Adjust pH to 7.4 
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NaCI 135 m M 
NaHP〇4 3.2 m M 
K H 2 P 0 4 0.5 m M 
KCI 1.3mM 
Tween 20 0.05% 
2.6.3) Primary antibodies 
Primary antibodies used for target proteins were diluted in 1 % B S A (dissolved 
in PBST) and incubated overnight at 4°C. Corresponding secondary antibodies 
were used at dilution 1:3000 and incubated for 1 hr at room temperature. 




W B (1:2000) Calbiochem 
Caspase-9 (C9) Mouse Monoclonal W B (1:1000) Cell 
signalling 
Caspase-8 (1C12) Mouse Monoclonal W B (1:1000) Cell 
IP (1:100) signalling 
Bcl-2 (50E3) Rabbit Monoclonal W B (1:1000) Cell 
IP (1:100) signalling 
p38 M A P K Rabbit Polyclonal W B (1:500) Cell 
signalling 
phos-p38 M A P K Mouse Monoclonal W B (1:500) Cell 
IP (1:50) signalling 
F (1:2000) 
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SAPK/JNK(56G8) Rabbit Monoclonal W B (1:500) Cell 
signalling 
JNKphosphorylated Mouse Monoclonal W B (1:500) Cell 
at Thr-183/Tyr-185 IP (1:250) signalling 
(pJNK) F (1:200) 
Actin Mouse Monoclonal W B (1:4000) Dako 
1
W B , IP, F indicated Western blot analysis, immunoprecipitation and flow 
cytometry respectively. 
2.7) Small interfering RNA experiment 
For the knockdown experiment, 8 0 % confluent cells were transfected with 
Opti-MEM (Cat no. 51985, Invitrogen) and Lipofectamine R N A i M A X (Cat no. 
13778075, Invitrogen) with the predesigned JNK1 siRNA (20nM, VHS40724, 
Invitrogen) and negative control siRNA (ambion) for 24 h. After transfection, 
medium was replaced with E B M without phenol red for B M P 4 treatment. 
2.8) Statistical analysis 
Results were calculated as mean 土 sem from n separate cell treatments. The 
apoptosis rate was expressed as the percentage of apoptotic cells present in 
each cell treatment. Protein expression analysis were normalized to p-actin 
and then expressed relative to control. Student f-test (unpaired two-tailed) or 
one-way A N O V A followed by Bonferroni post-tests was used when more than 
two treatments were compared. Levels of probabilities of less than 0.05 were 
regarded as significant. 
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CHAPTER III 
BMP4 induces endothelial cell apoptosis in 
ROS related p38 MAPK and JNK mediated 
caspase-3 dependent pathway 
3.1) Introduction 
Elevated level of endothelial cell apoptosis is associated with pathogenesis of 
human diseases, such as failing heart (Hetts 1998), advanced and unstable 
atherosclerotic plaque (Bauriedel etal. 1999), hypertension (Okura et al. 2002), 
and graft arteriosclerosis (Moldovan et al. 1998). Recently, endothelial cell 
apoptosis has found to contribute to the development of atherosclerosis by 
increasing the permeability of endothelial monolayer and subsequent uptake of 
lipids in the vessel wall (Choy et al. 2001). Clinical studies also suggest the 
contributory roles of endothelial cell apoptosis in plaque destabilization and 
thrombosis (Tricot et al. 2000). In atherosclerotic plaques, endothelial cells 
undergoing apoptosis produce high levels of apoptotic blebs are detected, 
accompanied by increased oxidative stress and the isolated blebs are able to 
stimulate binding of monocytes to endothelial cells (Coleman et al. 2001, 
Mallat and Tedgui 2001, Huber et al. 2002). In addition, in vitro studies show 
that high glucose-induced endothelial cell apoptosis with increased oxidative 
stress contributes to the reduction of N O bioavailability and in turn leads to 
endothelial dysfunction in diabetes mellitus (Ho et al. 2000). Therefore, studies 
on mechanisms of endothelial cell apoptosis will provide clues for elucidating 
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potential novel targets for therapeutic intervention in a wide range of vascular 
events. 
Reactive oxygen species (ROS) are well-known to be the important 
mediators of cell apoptotic responses (Finkel 2001b’ Simon 2000). Previous 
studies demonstrated that endothelial cell apoptosis is mediated by R O S upon 
various stimuli, including hypothermia (Rauen et al. 1999), hyperglycemia (Du 
1999), tumor necrosis factor (Deshpande et al. 2000)，and angiotensin II 
(Dimmeler and Zeiher 2000). Moreover, a higher number of apoptotic 
endothelial cells with increased oxidative stress is detected in atherosclerotic 
plaques and the enhanced production of R O S is found to involve the lesion 
formation (Alexander 1995). These findings suggest an important role of R O S 
in inflammatory responses of blood vessels. The reduced NAD(P)H oxidase is 
know to release R O S ; the latter mediate vascular inflammation under 
oscillatory shear stress conditions (Hwang et al. 2003). It is also known that the 
release of R O S that is triggered by pro-inflammatory cytokines and oxidized 
lipoproteins including TNF - a and oxLDL, can stimulate endothelial cell 
apoptosis and inhibition of the NAD(P)H oxidase protect against endothelial 
cell apoptosis (Li et al. 1999)， hence, further supporting that NAD(P)H 
oxidase-derived R O S plays a key role in endothelial cell apoptosis and leads to 
the release of apoptotic blebs which contribute to vascular inflammation. 
The presences of B M P 2 , B M P 4 and B M P 6 have been detected in 
atherosclerotic plaques (Bostrom et al. 1993, Dhore et al. 2001, Schluesener 
and Meyermann 1995). B M P s were first discovered as bone growth factors (Li 
and Wozney 2001) and B M P 2 and B M P 4 are identified as genes mediating 
inflammatory response to oscillatory shear stress in endothelial cells (Sorescu 
et al. 2003). In addition, the expression of B M P 2 is up-regulated in endothelial 
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, and high intraluminal 
pressure (Csiszar et al. 2005). Although the upstream stimuli for regulating 
their expression are different, they both exert similar pro-inflammatory actions. 
They are evidently up-regulated in the calcified atherosclerotic plaque and 
aortic valvular diseases, indicating the importance of B M P s in the pathology of 
cardiovascular diseases (Dhore et al. 2001, Bostrom et al. 1993, Mohler et al. 
2001). In mouse aortas, B M P 4 impairs vasorelaxations through by the 
increased production of R O S via activation of the N A D P H oxidase (Miriyala et 
al. 2006). Moreover, Sorescu et al. (2003) demonstrated that B M P 4 
up-regulated by oscillatory shear stress elevated the R O S production and led 
to ICAM-1 over-expression, causing monocyte adhesion (Sorescu G P et al. 
2003). Although endothelial cell apoptosis is known to participate in the 
occurrence of vascular inflammation, the exact underlying mechanisms by 
which B M P 4 , a novel pro-inflammatory factor, is involved remain largely 
unknown. 
Despite of the classical intracellular signaling pathway initiated by B M P s 
which involves the receptor mediated S m a d proteins activation, there have 
been growing evidences showing that B M P s activate M A P K s and S A P K s 
signaling cascades, including ERK, p38 M A P K and J N K in a cell-specific 
manner (Jeffery et al. 2005). B M P 4 were found to activate the M A P K s in lung 
fibroblasts (Jeffery et al. 2005) and in pulmonary artery myocytes (Yang et al. 
2007). Conventionally, M A P K and S A P K pathways play an important role in 
regulating cellular metabolisms in response to different stimuli, such as 
oscillatory shear stress. E R K is well-known to be responsible for growth 
stimulion. Both J N K and p38 M A P K are activated by various cellular and 
environmental stress, such as D N A damage, heat shock, ischemia, 
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inflammatory cytokines, ultra-violet irradiation ceramide or oxidative stress 
(Tibbies and Woodgett 1999’ Widmann et al. 1999’ Davis 2000, Chang and 
Karin 2001, Johnson and Lapadat 2002, Dent et al. 2003). They are involved in 
regulations of cell death mechanisms (Wada and Penninger 2004). Previous 
studies showed that M A P K s is the downstream targets in ROS-induced cell 
apoptosis, for instance, H202 activates MAPKs in rat VSMC (Guyton et al. 
1996). However, there is no information available in literature regarding 
whether M A P K s are involved in signaling cascade triggered by BMP4-induced 
R O S release in endothelial cells, eventually leading to vascular inflammation. 
In the present study, I hypothesized that BMP4-induced endothelial cell 
apoptosis in a ROS-dependent manner and that exogenous BMP4-induced 
endothelial cell apoptosis is mediated through ROS-dependent activation of 
p38 M A P K - and JNK-dependent pathways. I aimed to suggest that inhibition of 
these mediators would contribute to the improvement of vascular function that 
is damaged by B M P 4 . 
38 
Chapter III) BMP4 induces endothelial cells apoptosis 
3.2) Methods and materials 
3.2.1) Isolation and culture of endothelial cells 
R A E C s were isolated from the aorta of male Sprague-Dawley rats weighed 
260-280g by digestion with 0.2% collagenase in P B S in a shaking bath for 15 
minutes at 37°C. The mixture was then centrifuged at 800g for 5 minutes and 
supernatant was removed. Cells were collected and suspended in R P M I 
medium 1640 containing 1 0 % fetal bovine serum (FBS) and 1 % penicillin and 
streptomycin (P/S), settled in a 75 c m
2
 flask, and incubated at 37°C in an 
atmosphere of 95%/5% humidified air/C0
2
 atmosphere for 1 hour. Medium 
was changed 1 hour after and then once every second day. To avoid possible 
impact of the culture condition on the endothelial cell properties, only cells of 
the first two passages maintained in the same culture condition for less than 
one week were used in the present study. 
H U V E C s were grown in E G M supplement with BBE, 1 % P/S. Cells were 
grown in 75 c m
2
 flasks and maintained at 37 °C in a 95%/5% humidified 
air/C0
2
 atmosphere. The experiments were performed on cells at passage 4-6 
when they grew an 80-90% confluency. 
3.2.2) Drugs treatment 
Before B M P 4 treatment was initiated, culture medium was changed to E B M 
containing 1 % P/S without phenol red. After obtaining the initial results on the 
time and dose required for apparent effect of B M P 4 on endothelial cell 
apoptosis, the involvement of R O S was assessed. Prior to B M P 4 treatment, 
cells were incubated with noggin (100 ng/ml for R A E C s and 300 ng/ml for 
HUVECs), apocynin (100 pM) or Tiron (1 m M ) plus D E T C A (100 pM) for 30 
minutes. 
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To study the role of M A P K s , endothelial cells were incubated with S B 
202190 (10 |JM), SP 600125 (10 |JM), PD 98059 (10 |JM) or DMSO as solvent 
control for 30 minutes, followed by exposure to B M P 4 . Cell apoptosis assay 
and Western blot analysis were then carried out to detect the cell death rate 
and protein expression. 
3.2.3) Assay for cell apoptosis 
3.2.3.1) Terminal deoxynucleotidyl transferase-mediated dUTP nick 
end-labeling (TUNEL) assay 
T U N E L assay was used to detect D N A fragmentation in situ according to the 
instructions provided in the assay kit (Chemicon). Briefly, cells were seeded on 
cover slip and fixed with 4 % paraformaldehyde overnight after drug treatment. 
Samples were pre-incubated in an equilibration buffer for 5 minutes and 
subsequently incubated with TdT enzymes for 1 hour at 37°C. The reaction 
was terminated by incubating samples in stop/wash solution for 10 minutes at 
room temperature. After three rinses in PBS, anti-digoxignin peroxidase 
conjugate was applied to samples for 30 minutes. After washing in P B S for four 
times, each sample was incubated with peroxidase substrate for about 10 
minutes for colour development. Staining was visualized as brown precipitate 
by using 3’ 3’-diamonobenzidine tetrachloride (DAB) chromogen substrate. 
The samples were then counterstained with Hematoxylin and Eosin. Images 
were taken under a microscope using software Spot Advanced. Apoptotic cells 
were counted as cells having condensed and fragmented nucleus. (Detailed 
information is given in section 2.3) 
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3.2.3.2) Cell death detection ELISA kit 
Cell death detection ELISA (Roche) was performed according to the 
manufacturer's instruction. Briefly, cells were lysed following drug treatment. 
After centrifugation, 20 |jl of the supernatant was transferred to the microplate 
and fleshly prepared immunoreagent was added. The plate was covered with 
foil and gently shaked for 2 hours between 15°C and 25°C. Then, the solution 
remained in wells was removed carefully and A B T S solution was added to 
each well. After incubation, samples were stopped by A B T S stop solution and 
optical density was read at 405 nm. 
3.2.3.3) Flow cytometric analysis 
For analyses of endothelial cell apoptosis, the apoptotic rate was measured by 
propidium iodide and annexin-V staining detected by the flow cytometry 
technique according to the manufacturer's instruction (BD pharmingen). Briefly, 
after drug treatment, cells were trypsinized and collected by centrifugation. The 
cells were washed and re-suspended in 1X binding buffer at concentration of 1 
x 10
6
 cells/ml. 1 x 10
 5
 cells were stained with 5 jjI propidium iodide and 5 pi 
annexin-V FITC for 15 minutes before analysis by flow cytometry (B&D 
FACSort). The instrument was set to collect 1 X 10
5
 cells and the profile was 
analyzed using CellQuest software. 
3.2.4) Western blot analysis 
After drug treatment, cells were trypsinized and homogenized in an ice-cold 
RIPA lysis buffer. Lysates were centrifuged and supernatants were collected. 
Protein concentrations were then determined. Protein samples (20 |JM) were 
separated on 1 0 % SDS-polyacrylamide gel and then transferred to a 
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nitrocellulose immobilon-P polyvinylidene difluoride membrane. The 
membrane was blocked with 1 % BSA. Primary antibodies for caspase-3, 
caspase-8, caspase-9, Bcl-2, phosphor-p38 M A P K , p38 M A P K , 
phospho-SAPK/JNK, SAPK/JNK and p-actin (related information can be found 
in Chapter II) and the corresponding secondary antibodies conjugated to 
horseradish peroxidase were used. The membranes were developed in 
enhanced chemiluminescence detection solutions and exposed onto X-ray 
films. Densitometry was performed using the documentation program. 
3.2.5) Dihydroethidium (DHE) staining 
After B M P 4 treatment, cells were incubated with 5 |jM dihydroethidium 
(Invitrogen) in P B S for 30 minutes at 37°C. After washed once in PBS, images 
were obtained with Olympus 750 (Olympus Fluoview) using a 40X objective 
with excitation/ emission filter 515/ 610 n m to visualize ethidium red 
fluorescence. The D H E fluorescent intensities were analyzed and quantified by 
Fluoview (version 1.5; F V 1 0 - A S W 1.5) (Detailed setting for laser scanning of 
images were described in section 2.5). 
3.2.6) Statistical analysis 
Results are expressed as mean 土 S E M and data was analyzed by Student's t 
test. The protein expression was normalized to (3-actin and then expressed 
relative to control. Statistical significance was determined by two-tailed 
Student's f-test or one-way A N O V A followed by Bonferroni post-tests when 
more than two treatments were compared. Levels of probabilities less than 
0.05 were regarded statistical significance. 
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3.3) Results 
3.3.1) Dose- and time-dependent effect of BMP4 
In order to examine whether B M P 4 induces endothelial cell apoptosis, the 
effect of B M P 4 on R A E C s in primary culture and H U V E C s were tested. Fig 3.1 
and 3.2 show that B M P 4 at 30 ng/ml significantly induced H U V E C apoptotic 
death, while Fig 3.3 shows that 10 ng/ml of B M P 4 caused significant apoptosis 
of R A E C s . 
As for the time-dependent effect of B M P 4 , 30 ng/ml of B M P 4 was used to 
treat H U V E C s for 24 hours and endothelial cell apoptosis was significantly 
higher as shown by ELISA (Fig 3.4) and flow cytometry analysis (Fig 3.5). 
Likewise, 24-hour treatment with 10 ng/ml of B M P 4 caused a significant 
increase in the apoptotic rate of R A E C s (Fig 3.6). 
3.3.2) Role of caspases in apoptosis of RAECs and HUVECs 
As caspases play an important role in cell apoptotic responses (Thornberry 
1998, Chowdhury, Tharakan and Bhat 2008), pro- and activated caspases 
were detected by Western blot analysis using the cell lysate. It is clear that 
B M P 4 induced time- (Fig 3.7) and dose- (Fig 3.8) dependent increase in 
caspase-3 activation in RAECs. Moreover, the protein level of cleaved 
caspsase-3 was also greatly elevated in H U V E C s exposed to B M P 4 (Fig 3.9). 
By contrast, the expression of caspase-8 (Fig 3.10), caspase-9 (Fig 3.11) and 
Bcl-2 (Fig 3.12) were not altered by B M P 4 in both cell types. This indicates that 
both caspase-8 and caspase-9 were unlikely to be involved in activation of 
caspase-3 in BMP4-induced endothelial cell apoptotic responses. 
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3.3.3) Roles of BMP4 and ROS in endothelial cell apoptosis 
3.3.3.1) Noggin antagonism of BMP4-induced effect 
Fig 3.13 shows that 300 ng/ml of noggin significantly inhibited BMP4-induced 
apoptosis of H U V E C s by ELISA and similar results could be obtained by using 
flow cytometry for the detection of annexin-V positive cells (Fig 3.14). For 
RAECs, 100 ng/ml of noggin was found to totally suppress the increased 
apoptotic rate in response to B M P 4 as assayed by T U N E L staining (Fig 3.15). 
Western blot analysis revealed that the protein level of cleaved caspase-3 (Fig 
3.16) was totally normalized in both noggin-treated R A E C s and H U V E C s . 
3.3.3.2) NAD(P)H oxidase-mediated ROS production 
Endothelial cells exposed to oscillatory shear stress were shown to release 
R O S from NAD(P)H oxidase resulting from the up-regulation of B M P 4 
(Sorescu et al. 2004), thus raising a question whether B M P 4 is directly 
responsible for the production of R O S derived from NAD(P)H oxidase in 
endothelial cells. Herein, BMP4-induced 0
2
'" production in endothelial cells 
was confirmed by D H E staining as B M P 4 (10 ng/ml) significantly increase 
intracellular generation of 0
2
" in R A E C s after 30-min treatment, approximately 
3-fold above the control (p<0.001), which was blocked by noggin, apocynin 
[NAD(P)H oxidase inhibitor] or tiron plus D E T C A (Fig 3.17). The present 
results further support that B M P 4 indeed stimulates NAD(P)H 
oxidase-dependent release of 0
2
" in endothelial cells. 
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3.3.3.3) Inhibition of endothelial cell apoptosis by ROS scavengers 
Next, I examined the role of R O S in BMP4-induced apoptosis by treating 
endothelial cells with apocynin or tiron plus D E T C A prior to apoptosis detection. 
The increased apoptotic rate (Fig 3.18 and 3.19) in BMP4-treated H U V E C s 
was reversed by drug treatments. In consistence with results obtained in 
H U V E C s , treatment of R A E C s with R O S scavengers or apocynin also 
normalized the apoptotic rate to the control level (Fig 3.20). Fig 3.21 shows 
that the level of the activated caspase-3 as detected by Western blot analysis 
was restored in both cell types. Collectively, the present results suggest that 
NAD(P)H oxidase-dependent R O S mediates BMP4-induced endothelial cells 
apoptosis. 
3.3.4) Roles of MAPKs/SAPKs in BMP4-induced endothelial cell 
apoptosis 
The involvement of p38 M A P K , E R K and J N K in BMP4-induced apoptosis in 
endothelial cells was investigated. S B 202190, P D 98059 and S P 600125 were 
used to inhibit p38 M A P K , E R K and JNK, respectively. In BMP4-treated 
H U V E C s , the apoptotic rate was significantly reduced by S B 202190 and S P 
600125, but not by P D 98059 (Fig 3.22 and 3.23). In R A E C s , B M P 4 induced 
apoptosis can also be reduced by the former two inhibitors (Fig 3.24). 
Furthermore, Western blot analysis shows that the elevated cleaved 
caspase-3 level was reversed by S P 600125 and S B 202190 in both H U V E C s 
(Fig 3.25 A) and R A E C s (Fig 3.25B). 
To further confirm the role of the activated p38 M A P K and JNK, R A E C s 
were treated with B M P 4 for different durations of time and then the level of 
phosphor-p38 M A P K and phosphor-JNK were detected. BMP4-stimulated 
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activation of p38 M A P K was evident at 2-h treatment (Fig 3.26), while JNK 1, 
but not J N K 2/3, was strongly activated at 4-h treatment (Fig 3.27). Therefore, 
p38 M A P K and J N K activation are clearly involved in BMP4-induced 
endothelial cell apoptosis. From the knockdown experiment, figure 3.32 shows 
that JNK1 siRNA can inhibit the JNK1 activity detected by western blot analysis. 
Moreover, JNK1 siRNA can completely blocked the B M P 4 induced apoptosis 
in H U V E C s detected from flow cyotmetry (Fig 3.33). From Western blot 
analysis (Fig 3.34), expression of cleaved caspase-3 was totally suppressed 
by JNK1 siRNA after B M P 4 treatment. JNK1 siRNA also completely restored 




 induced caspase-3 cleavage in endothelial cells. 
3.3.5) Relationship between ROS and MAPKs/SAPKs 
To test whether the activation of p38 M A P K and J N K was associated with the 
increased R O S production by B M P 4 , noggin, apocynin and R O S scavengers 
were used. Fig 3.28 shows that increased level of phosphor-p38 M A P K was 
totally prevented by treatment with noggin, apocynin or tiron plus D E T C A 
although there was no change in the expression of total p38 M A P K at 2-h 
B M P 4 treatment. O n the other hand, the elevated phosphor-JNK1 level 
stimulated by 4-hour exposure to B M P 4 was also abolished by noggin, 
apocynin and tiron plus D E T C A . Again, no change can be detected in the 
expression of J N K 2/3 and the total level of J N K (Fig 3.29). 
3.3.6) Relationship between p38 MAPK and JNK 
For further elucidate the crosstalk between p38 M A P K and J N K in 
BMP4-induced endothelial cell apoptosis, the effect of the p38 M A P K inhibitor 
on J N K activation or the effect of JNK inhibitor on p38 M A P K activation were 
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examined. Western blot analysis shows that the increased level of 
phosphor-p38 M A P K in R A E C s was not altered by the J N K inhibitor S P 
600125 following 2-hour B M P 4 treatment (Fig 3.30). O n the other hand, 
activation of J N K 1 following 4-hour B M P 4 treatment in R A E C s w a s reduced 
significantly by S B 202190 and S P 600125 while both inhibitors had no effect 
on the total J N K level (Fig 3.31). 
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Figure 3.1. Dose-dependent effect of B M P 4 in H U V E C s . Endothelial cells 
were treated with 10 ng/ml, 30 ng/ml and 100 ng/ml B M P 4 , respectively, for 24 
hours and the apoptotic rate was measured by Cell Death Detection ELISA, 
indicated as absorbance at 405 nm. Results are mean±sem of 3 experiments. 
Statistical significance between groups is indicated by ** p< 0.01, *** p< 0.001 
(vs Control). 
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Figure 3.2. Dose-ucpci lucm cncui ui divith iii n u vtzo apuptuaia assayed by 
flow cytometry. (A) Representative figures of the determination of apoptosis by 
propidium iodide (PI) and annexin-V FITC staining analyzed by flow cytomtery 




 for 30 min 
served as a positive control. (B) Summarized data for flow cytometric analysis 
of apoptosis in H U V E C s following 24-hour treatment with B M P 4 . Results are 
mean土sem of 4 experiments. Statistical significance between groups is 
indicated by *** p< 0.001 (vs Control). 
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Figure 3.3. Dose-dependent effect of B M P 4 in cultured rat endothelial cells 
(RAECs). R A E C s were treated with different doses of B M P 4 for 24 h and the 
apoptotic response w a s determined by T U N E L staining. (A) Representative 
images showing that apoptotic cells possessed condensed and fragmented 
nucleus. (B) Summarized data obtained from cells showing positive T U N E L 
staining. Results are mean土sem of 4 experiments. Statistical significance 
between groups is indicated by *** p< 0.001 (vs Control). 
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Figure 3.4. Time-dependent effect of B M P 4 on H U V E C apoptosis. Cells were 
treated with 30 ng/ml B M P 4 for 12, 24 and 36 hours and the apoptotic rate was 
determined by Cell Death Detection ELISA, as indicated by absorbance at 405 
nm. Results are mean士sem of 3 experiments. Statistical significance between 
groups is indicated by ** p< 0.01 (vs 12-h Control). 
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Figure 3.5. H U V E C s were treated with 30 ng/ml B M P 4 for 12 h, 24 h and 36 h. 
After treatment, cell apoptosis was detected by flow cytometry. (A) 
Representative figures of cell apoptotic rate detected as annexin-V FITC 
positive cells. (B) Summarized data for flow cytometric analysis of H U V E C 
apoptosis after B M P 4 treatment for different periods of time. Results are 
mean土sem of 4 experiments. Statistical significance between groups is 
indicated by *** p< 0.001 (vs time-matched Control). 
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Figure 3.6. Time-dependent effect of B M P 4 on R A E C s . R A E C s were treated 
with 10 ng/ml B M P 4 for 12 h, 24 h and 36 h. After treatment, T U N E L staining 
w a s performed to assess cell apoptosis. (A) Representative images of R A E C s 
incubated with B M P 4 for different durations of time. (B) Summarized data for 
R A E C s with T U N E L positive staining. Results are mean士sem of 4 experiments. 
Statistical significance between groups is indicated by *** p< 0.001 (vs 
time-matched Control). 
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Figure 3.7. Dose-dependent effect of B M P 4 on the caspase-3 expression in 





 as the positive control. The protein levels of procaspase-3 (39 
kDa), cleaved caspase-3 (20 kDa) and p-actin (42 kDa) were detected by 
Western blotting method. Summarized data were expressed relative to control. 
Results are mean土sem of 4 experiments. Statistical significance between 
groups is indicated by ** p< 0.01 (vs Control). 
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Figure 3.8. Time-dependent effect of B M P 4 on the caspase-3 expression in 
RAECs. R A E C s were treated with 10 ng/ml B M P 4 and vehicle control for 12 h, 
24 h and 36 h. The protein levels of procaspase-3 (39 kDa), cleaved caspase-3 
(20 kDa) and (3-actin (42 kDa) were detected by Western blotting method. 
Summarized data were expressed relative to control. Results are mean±sem 
of 4 experiments. Statistical significance between groups is indicated by ** p< 
0.01 (vs Control). 
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Figure 3.9. Effect of B M P 4 on the caspase-3 expression in H U V E C s . H U V E C s 
were treated with 30 ng/ml B M P 4 and vehicle control for 24 h. The protein 
levels of procaspase-3 (39 kDa), cleaved caspase-3 (20 kDa) and actin (42 
kDa) were detected by Western blotting method. Summarized data were 
expressed relative to control. Results are mean土sem of 4 experiments. 
Statistical significance between groups is indicated by *** p< 0.001 (vs 
Control). 
56 
Chapter III) BMP4 induces endothelial cells apoptosis 
A B 
HUVEC R A E C -
“ . • procaspase-8 . v 
procaspase-8 H — i i - M I B ; 
cleaved caspase-8 — . 一





p - a c mmm — • • • 
5 ？ S I 
^ 1 3 1 I % § 3 1 
a) oj o 2- JS 5 S 2-
03 Q. +-
1
 05 CL ― 
O W -T5 o W -a 




 1 1 
^ � / / ^ � / / 
Figure 3.10. The effect of B M P 4 on the caspase-8 expression in endothelial 
cells. Western blot analysis of procaspase-8 (57 kDa), cleaved caspase-8 (18 
kDa) and [3-actin (42 kDa) were performed. (A) H U V E C s were treated with 30 
ng/ml B M P 4 and vehicle control for 24 h. (B) R A E C s were treated with 10 
ng/ml B M P 4 and vehicle control for 24 h. Summarized data were expressed 
relative to control. Results are mean土sem of 4 experiments. 
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Figure 3.11. The effect of B M P 4 on the caspase-9 expression in endothelial 
cells. Western blot analysis of procaspase-9 (51 kDa), cleaved caspase-9 (35 
kDa) and (3-actin (42 kDa) were performed. (A) H U V E C s were treated with 30 
ng/ml B M P 4 and vehicle control for 24 h. (B) R A E C s were treated with 10 
ng/ml B M P 4 and vehicle control for 24 h. Summarized data were expressed 
relative to control. Results are mean士sem of 4 experiments. 
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Figure 3.12. The effect of B M P 4 on the Bcl-2 expression in endothelial cells. 
Western blot analysis of Bcl-2 (26 kDa), p-actin (42 kDa) were detected. (A) 
H U V E C s were treated with 30 ng/ml B M P 4 and vehicle (Control) for 24 h, 
while (B) R A E C s were treated with 10 ng/ml B M P 4 and vehicle (Control) for 24 
h. Intensities were normalized to p-actin and expressed relative to control. 
Results are mean士sem of 4 experiments. 
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Figure 3.13. The effect of treatment with noggin in H U V E C s . Cell death 
detection ELISA w a s used to detect cell apoptosis. H U V E C s were pre-treated 
with 300 ng/ml noggin for 30 min and then exposed to 30 ng/ml B M P 4 for 24 
hours. After treatment, the cell lysate was collected for ELISA measurement at 
405 n m . Summarized data was expressed relative to vehicle control. Results 
are mean土sem of 3 experiments. Statistical significance between groups is 
indicated by ** p< 0.01 (vs 30 ng/ml B M P 4 ) 
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Figure 3.14. The effect of treatment with noggin in H U V E C apoptosis as 
detected by flow cytometry. H U V E C s were pre-treated with 300 ng/ml noggin 
for 30 min, followed by treatment with 30 ng/ml B M P 4 for 24 h. After treatment, 
flow cytometry w a s used to detect apoptotic cells with annexin-V FITC positive 
stain. (A) Representative images for the determination of cell apoptosis by flow 
cytometry and (B) Summarized data for flow cytometric analysis of H U V E C 
apoptosis rate after noggin and B M P 4 treatment. Results are mean士sem of 3 
experiments. Statistical significance between groups is indicated by * p< 0.05 
(vs 30 ng/ml BMP4). 
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Figure 3.15. T h e effect of treatment with noggin on R A E C s as detected by 
T U N E L staining. R A E C s were pre-treated with 100 ng/ml noggin for 30 min, 
followed by treatment with 10 ng/ml B M P 4 for 24 h. After treatment, T U N E L 
staining w a s used to detect apoptotic cells. (A) Representative images of 
determination of cell apoptosis by T U N E L staining and (B) summarized data 
expressed as percentage of positive cells measured. Results are mean土sem 
of 4 experiments. Statistical significance between groups is indicated by *** p< 
0.001 (vs 10 ng/ml B M P 4 ) . 
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Figure 3.16. The effect of treatment with noggin on the caspase-3 expression 
in endothelial cells. Western blot analysis of procaspase-3 (39 kDa), cleaved 
caspase-3 (20 kDa) and p-actin (42 kDa) was performed in (A) H U V E C s 
treated with 300 ng/ml noggin and (B) R A E C s treated with 100 ng/ml noggin 
30 min before 24-hour treatment with B M P 4 . Summarized data was expressed 
as relative to control. Results are mean土sem of 4 experiments. Statistical 
significance between groups is indicated by * p<0.05 and *** p<0.001 (vs only 
B M P 4 treatment). 
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Figure 3.17. T h e effect of B M P 4 on the R O S production in endothelial cells 
detected by dihydroethidium (DHE) fluorescence intensity. R A E C s were 
treated with noggin, apocynin, tiron plus D E T C A and D M S O as solvent control 
for 30 min before 30-min exposure to 10 ng/ml B M P 4 . (A) Representative 
images showing D H E fluorescent intensities under different drug interventions 
and (B) summarized data expressed as intensities relative to control. Results 
are mean土sem of 4 experiments. Statistical significance between groups is 
indicated by *** p< 0.001 (vs Control) and ## p< 0.01 (vs 10 ng/ml B M P 4 ) 
(calibration bar represents 100 |jm). 
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Figure 3.18. Summarized data from the use of cell death detection ELISA Kit. 
After initial 30-min treatment with apocynin or tiron plus D E T C A , H U V E C s 
were exposed to 30 ng/ml B M P 4 for 24 h. The cell lysate was collected for 
ELSIA measurement. Data was expressed relative to vehicle control. Results 
are mean±sem of 3 experiments. Statistical significance between groups is 
indicated by * p<0.05 and ** p<0.01 (vs 30 ng/ml BMP4). 
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Figure 3.19. Inhibition of the R O S production on BMP4-induced H U V E C 
apoptosis. H U V E C s were pre-treated with apocynin or tiron plus D E T C A for 30 
min, followed by 24-hour exposure to 30 ng/ml B M P 4 . After treatment, flow 
cytometry was used to detect apoptotic cells with annexin-V FITC positive 
stain. (A) Representative images for determination of cell apoptosis by flow 
cytometry and (B) Summarized data for flow cytometric analysis of H U V E C 
apoptosis rate. Results are mean土sem of 3 experiments. Statistical 
significance between groups is indicated by * p< 0.05 (vs 30 ng/ml BMP4). 
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Figure 3.20. Inhibition of the ROS production on BMP4-induced apoptosis in 
RAECs. RAECs were pre-treated with apocynin for 30 min, followed by 
24-hour exposure to 10 ng/ml BMP4. After treatment, TUNEL staining was 
used to detect apoptotic cells. (A) Representative images for determination of 
cell apoptosis by TUNEL staining and (B) summarized data expressed as 
percentage of positive cells measured. Results are mean土sem of 4 
experiments. Statistical significance between groups is indicated by *** 
p<0.001 (vs 10 ng/ml BMP4). 
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Figure 3.21. The effect of inhibition of the R O S production on the caspase-3 
expression in endothelial cells. Western blot analysis of procaspase-3 (39 kDa), 
cleaved caspase-3 (20 kDa) and (3-actin (42 kDa) was performed in (A) 
H U V E C s and (B) R A E C s that were pre-treated with apocynin, tiron plus 
D E T C A or D M S O for 30 min before 24-hour exposure to B M P 4 . Summarized 
data was expressed as relative to control. Results are mean士sem of 4-5 
experiments. Statistical significance between groups is indicated by * p<0.05 
and ** p<0.001 (vs B M P 4 treatment). 
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Figure 3.22. The effect of M A P K inhibitors. Summarized data from the use of 
cell death detection ELISA Kit. After initial 30-min treatment with S B 202190’ 
S P 600125 or P D 98059, respectively, for 30 min, H U V E C s were exposed to 
30 ng/ml B M P 4 . The cell lysate was collected for ELSIA measurement. Data 
was expressed relative to vehicle control. Results are mean土sem of 3 
experiments. Statistical significance between groups is indicated by * p<0.05 
(vs 30 ng/ml BMP4). 
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Figure 3.23. The effect of M A P K inhibitors on BMP4-induced H U V E C 
apoptosis. H U V E C s were pre-treated with different M A P K s inhibitors for 30 
min, followed by 24-hour exposure to 30 ng/ml B M P 4 . After treatment, flow 
cytometry was used to detect apoptotic cells with annexin-V FITC positive 
stain. (A) Representative images and (B) summarized data for the flow 
cytometric results. Results are mean±sem of 3 experiments. Statistical 
significance between groups is indicated by * p<0.05, *** p<0.001 (vs 30 ng/ml 
BMP4). 
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Figure 3.24. The effect of MAPK inhibitors on BMP4-induced apoptosis in 
RAECs. RAECs were pre-treated with different MAPKs inhibitors for 30 min, 
followed by 24-hour exposure to 10 ng/ml BMP4. After treatment, TUNEL 
staining was used to detect apoptotic cells as showed in (A) representative 
images and (B) summarized data expressed as percentage of positive cells 
measured. Results are mean土sem of 4 experiments. Statistical significance 
between groups is indicated by *** p<0.001 (vs 10 ng/ml BMP4). 
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Figure 3.25. Effects of M A P K inhibitors on the caspase-3 expression in 
endothelial cells. Western blot analysis of procaspase-3 (39 kDa), cleaved 
caspase-3 (20 kDa) and (3-actin (42 kDa) was performed in (A) H U V E C s and 
(B) R A E C s that were pre-treated with different M A P K inhibitors for 30 min 
before 24-hour exposure to B M P 4 . Summarized data was expressed as 
relative to control. Results are mean土sem of 4-5 experiments. Statistical 
significance between groups is indicated by ** p<0.001 (vs B M P 4 treatment). 
72 
Chapter III) BMP4 induces endothelial cells apoptosis 
Oh 30min 2h 4h 8h 12h 24h 
10 ng/ml B M P 4 - + - + - + + + + 
phospho-p38 M A P K . ，： . m ^ m 處 rn m 訟 麟 
p38 M A P K . ^ttt^ ^ MMM^^iHMMM^ ^ gp g^MMi^  ^ ^ ^ ^hmt ^••iP' 
"
c t i n





2S < -a ** 
a . ^ 2 2 - X ； i * 
r t i i i l l h 
I I » » — I — I — I — • 
Figure 3.26. The effect of B M P 4 on the levels of p38 M A P K in R A E C s . After 
treatment with 10 ng/ml B M P 4 for 30 min, 2, 4, 8, 12 and 24 h, respectively, the 
p38 M A P K and phosphor-p38 M A P K levels were detected by Western blotting 
method. All data are presented as mean 土 S E M in 4 experiments. * p<0.05; ** 
p<0.01 and *** p<0.001(vs 0 h). 
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Figure 3.27. The effect of B M P 4 on the levels of J N K in RAECs. After 
treatment with 10 ng/ml B M P 4 for 30 min, 2’ 4, 8, 12 and 24 h, respectively, the 
J N K and phosphor-JNK were then detected by Western blotting method. All 
data are presented as mean 土 S E M in 4 experiments. * p<0.05; ** p<0.01 (vs 0 
h). 
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Figure 3.28. The effect of noggin and inhibition of R O S production on the 
activation of p38 M A P K in BMP4-treated endothelial cells. R A E C s were 
treated with noggin, tiron plus D E T C A , apocynin, or D M S O for 30 min before 
2-hour exposure to B M P 4 , phophor-p38 M A P K and total p38 M A P K levels 
were then detected by Western blotting method. All data are presented as 
mean 土 S E M in 4 experiments. *** P<0.001 (vs Control), # p<0.05, ## p<0.01 
(vs 10 ng/ml BMP4). 
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Figure 3.29. The effect of noggin and inhibition of R O S production on 
activation of J N K in BMP4-treated endothelial cells. R A E C s were treated with 
noggin, tiron plus D E T C A , apocynin, or D M S O for 30 min before 4-hour 
exposure to B M P 4 , phosphor-JNK and J N K levels were then detected by 
Western blotting method. All data are presented as mean 士 S E M in 4 
experiments. Statistical difference was indicated by ** p<0.01 (vs Control), # 
p<0.05, ## p<0.01 (vs 10 ng/ml BMP4). 
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Figure 3.30. The effect of J N K inhibition on the activation of p38 M A P K in 
BMP4-treated endothelial cells. R A E C s were treated with S P 600125 or 
D M S O for 30 min before 2-hour exposure to B M P 4 , phosphor-p38 M A P K and 
total p38 M A P K levels were detected by Western blotting method. All data are 
presented as mean 土 S E M in 4 experiments. 
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Figure 3.31. The effect of p38 M A P K inhibition on the activation of J N K in 
BMP4-treated endothelial cells. R A E C s were treated with S B 202190，SP 
600125 or D M S O for 30 min before 4-hour exposure to B M P 4 , phosphor-JNK 
and total J N K levels were then detected by Western blotting method. All data 
are presented as m e a n 土 S E M in 4 experiments. Significant difference is 
indicated by # p<0.05 (vs 10 ng/ml BMP4). 
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Figure 3.32. JNK1 siRNA completely knockdown the JNK activity 
detected by Western blot. H U V E C s were treated with 20nM JNK1 siRNA 
using lipofatamine R N A i M A X for 24 h. JNK levels were then detected by 
Western blotting method. Bands shown are respresentative of 3 independent 
experiments. 
79 
Chapter III) BMP4 induces endothelial cells apoptosis 
0
s J N K 1 
> Control siRNA S 
•g 40] 大 大大大 
II iili 
、。 I I I I I I I I I I I r -
^ I 2 o 1
2
 o o - 1 2； o 
§ 5 5
 X
o | > < 3 ： o l > < X 
Figure 3.33. The effect of JNK1 siRNA on BMP4-induced H U V E C apoptosis. 
H U V E C s were transfected with 20nM JNK1 siRNA for 24 hour, followed by 





treatment, flow cytometry was used to detect apoptotic cells with annexin-V 
FITC positive stain. Treatment in control is only with lipofatamine RANiMAX. 
Summarized data for the flow cytometric results. Results are mean±sem of 3 
experiments. Statistical significance between groups is indicated by * p<0.05, 
*** p<0.001 (vs control), s indicates sramble siRNA. 
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Figure 3.34. Effects of JNK1 siRNA on the caspase-3 expression in H U V E C s . 
Western blot analysis of procaspase-3 (39 kDa), cleaved caspase-3 (20 kDa) 
and p-actin (42 kDa) was performed H U V E C s that were pre-treated with 20nM 
JNK1 siRNA and scramble siRNA with lipofatamine R N A i M A X for 24 hour 
before 24-hour exposure to B M P 4 . Summarized data was expressed as 
relative to control (with lipofatamine only). Results are mean士sem of 4-5 
experiments. Statistical significance between groups is indicated by * p<0.05, 
** p<0.001 (vs Control). 
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3.4) Discussion 
The present study provides novel findings regarding the significant role of 
B M P 4 , a novel pro-inflammatory biomarker, in endothelial cells apoptosis. 
Oscillatory shear stress was shown to up-regulate the B M P 4 production in 
endothelial cells, leading to increased monocyte adhesion (Sorescu et al. 2003’ 
Sorescu et al. 2004). A few recent studies suggest that B M P 4 plays a crucial 
role in hypertension (Miriyala et al. 2006) and atherosclerosis (Dhore et al. 
2001, Bostrom et al. 1993, Mohler et al. 2001). B M P 4 was shown to induce 
hypertension through activation of NAD(P)H oxidase (Miriyala et al. 2006) • 
However, little is known about the underlying mechanisms related to 
BMP4-induced vascular inflammation. Increased endothelial cell apoptosis is 
reported to contribute to the development of atherosclerosis (Bauriedel et al. 
1999) and hypertension (Okura et al. 2002). The present study demonstrates 
that exogenous B M P 4 induced endothelial cell apoptosis via a caspase-3 
dependent mechanism in association with increased R O S production via 
stimulation of NAD(P)H oxidase, and this mechanism may be involved the 
development of atherosclerotic plaques in response to oscillatory shear stress. 
3.4.1) Caspase-dependent pathways 
Previous studies showed a significant role of activation of various caspases in 
endothelial cell apoptosis. For instance, TNF - a has been proven to induce cell 
apoptosis by ligand-bound death receptors, such as Fas, T N F R 1 or the TRAIL 
receptors D R 4 and DR5, mediated through Fas associated death domains 
(FADD) and activation of caspase-8 (Chinnaiyan et al. 1995). Although the 
expression of both Fas and Fas-ligand was detected in endothelial cells, 
endothelial cells m a y be resistant to Fas-mediated apoptosis under normal 
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conditions. However, upon stimulation and injuries, endothelial cells become 
dramatically sensitized to the Fas-mediated apoptotic process (Sata and 
Walsh 1998b, Sata and Walsh 1998a). It was shown before that oxidized LDL 
induces endothelial cell apoptosis by activating the Fas death pathway and 
enhances the sensitivity of endothelial cells to Fas-mediated cell death which 
disrupts the integrity of endothelium, eventually resulting in the occurrence of 
vascular diseases, such as atherosclerosis (Sata and Walsh 1998a). 
Apart from the Fas-mediated death receptor pathway, another 
caspase-dependent mechanism is also implicated in the oxidized LDL-induced 
endothelial cells apoptosis, namely the extrinsic apoptotic pathways which 
include Bcl-2 family members, cytochrome c and caspase-9 (Salvayre et al. 
2002, Li 1998a, Sata and Walsh 1998a). Oxidized LDL triggers a signaling 
cascade involving Bid cleavage and cytochrome c release, leading to the 





 induces endothelial cell apoptosis through a mitochondria-dependent 
mechanism involving the activation of caspsase-9 (Lu et al. 2007). 
Both the mitochondrial and death receptor pathways activate the same 
downstream target, caspase-3, and lead to apoptosis (Schmitz et al. 2000). 
The present results clearly demonstrate a time- and dose-dependent induction 
of endothelial cell apoptosis in response to B M P 4 in both H U V E C s and R A E C s . 
Moreover, Western blot results also show that B M P 4 increased the level of the 
cleaved caspase-3 by approximately 1.5-fold in both cell types, further 
supporting the apoptotic effect of B M P 4 mediated by caspase-3 activation. 
Caspase-3 was proven to be an effector caspase which switches on the 
downstream process, such as D N A damage, and response to death stimuli 
(Chowdhury et al. 2008). As oxidized LDL is reported to exert an apoptotic 
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effect in endothelial cells via both death receptor and mitochondrial pathways, 
B M P 4 m a y also exert its apoptotic effect through these similar mechanisms. It 
is, therefore, logical to investigate the cellular events in relation to the 
upstream of caspase-3 upon stimulation by B M P 4 . In the present study, 
pro-caspase-8 was first found to be expressed in endothelial cells (Fig 3.10) 
and the activation of caspase-8 was then detected for assessment of possible 
involvement of the Fas-ligand death receptor pathway. O n the other hand, the 
present results show that both caspase-9 and Bcl-2 were expressed in 
endothelial cells (Fig 3.11 and 3.12). Since caspase-9 is activated by the 
increased release of cytochrome c or/and the reduced expression and activity 
of Bcl-2, an anti-apoptotic protein, the expression of cleaved caspase-9 and 
Bcl-2 were examined for assessment of the possible involvement of the 
mitochondrial pathway. However, there was no change in the expression of 
caspase-8 (Fig 3.10), caspase-9 (Fig 3.11), or Bcl-2 (Fig 3.12) in endothelial 
cells subjected to B M P 4 challenge. M y results suggest that the activation of 
caspase-3 is probably independent of Fas-mediated death receptor and 
mitochondrial signaling pathways. 
Earlier studies in literature showed that the endoplasmic reticulum also 
plays a role in the regulation of cell death via the activation of caspase-3 
(Kaufman 1999, Ferri and Kroemer 2001) and also attribute to activation of 
caspase-12 in response to stimuli such as hypoxia (Szegezdi 2003). More 
recently, B M P 4 was showed to induce apoptosis of myeloma cells through 
endoplasmic reticulum dysfunction (Fukuda et al. 2006), further revealing the 
possible upstream mechanism involving the endoplasmic reticulum 
dysfunction in BMP4-induced activation of caspase-3 in endothelial cells. 
The release of cytochrome c is associated with activation of caspase-9. 
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Although I did not measure the cytochrome c release in the present study, the 
relevant information shall help to indicate whether or not the mitochondrial 
pathway is involved in BMP4-induced endothelial cell apoptosis. Of course, 
measurement of the activities of various forms of caspases would provide 
more direct evidence for different roles caspases m a y play in apoptotic 
response to B M P 4 . 
3.4.2) Oxidative stress 
B M P antagonist noggin prevented BMP4-induced R O S production and 
apoptosis in endothelial cells, suggesting that effect of B M P 4 is specific in 
endothelial cells. 
R O S generated by a variety of mechanisms play an important role in 
pathogenesis of cardiovascular diseases. R O S induces endothelial cell 
apoptosis and V S M C s growth in association with hypertension, atherosclerosis 
and heart failure (Lopez Farr6 and Casado 2001). Existing evidence shows 
that R O S mediates endothelial cell apoptosis in response to cytokine and 
chemotherapeutic drugs (Dimmeler et al. 1997c, Kotamraju et al. 2000’ Du et 
al. 1999’ Rauen et al. 1999, Deshpande et al. 2000). B M P 4 has been shown to 
exert apoptotic effect in microvascular and human umbilical cord vein 
endothelial cells, and the over-expression of inhibitory S m a d proteins protects 
endothelial cells against BMP4-induced apoptosis (Kiyono and Shibuya 2006) 
and myeloma cells (Fukuda et al. 2006). However, it is totally unknown 
whether the over-production of R O S resulted from B M P 4 stimulation 
participates in the apoptotic signaling cascade in endothelial cells. In the 
present study, D H E fluorescence imaging shows that B M P 4 is a potent 
stimulator of R O S production in endothelial cells upon a brief 30-min exposure. 
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The over-production of 0
2
" can be abolished by R O S scavengers, tiron plus 
D E T C A . Increased endothelial cell apoptosis was also reversed by R O S 
removal as shown by flow cytometry (Fig 3.19) and T U N E L staining (Fig 3.20). 
The present novel findings suggest that R O S is the most likely mediator of the 
BMP4-induced endothelial cell apoptosis. 
O n the other hand, the pathological role of NAD(P)H oxidase has been 
reported in salt-induced hypertensive rate and there were up-regulated 
expression of NAD(P)H oxidase subunits in left ventricles of hypertensive rats 
(Yoshida et al. 2007). B M P 4 was described to induce endothelial dysfunction in 
mice aortas via the activation of NAD(P)H oxidase (Miriyala et al. 2006). This 
raises a question whether NAD(P)H oxidase activated by B M P 4 is involved in 
the induction of endothelial cell apoptosis. The present study shows that 
inhibition of NAD(P)H oxidase by apocynin significantly suppressed the R O S 
production as well as the elevated apoptotic rate in response to B M P 4 in rat 
and human endothelial cells (Fig 3.18-20). Taken together, the present results 
support a essential role of NAD(P)H oxidase-derived R O S in BMP4-induced 
endothelial cell apoptosis. 
Since there are two types of B M P receptor found on the endothelial cells, 
namely B M P type I receptor and B M P type II receptor (Dale and Jones 1999’ 
Kawabata 1998)，it has been widely shown that B M P s exert their effect by 
binding to the receptors, generally, type I receptor has higher binding affinity to 
B M P s . Although it is clearly demonstrated that B M P 4 activated R O S 
production from NAD(P)H oxidase, further studies are needed to be carried out 
to elucidate whether the B M P 4 effect is mediated by B M P receptors in the 
apoptotic pathway. 
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3.4.3) Role of MAPKs activation in BMP4-induced endothelial cell 
apoptosis 
The present results show that BMP4-induced endothelial cell apoptosis 
depended upon the activation of p38 M A P K and JNK, but not ERK. 
Pharmacological inhibition of p38 M A P K with S B 202190 and J N K with S P 
600125 significantly attenuated the induction of endothelial cell apoptotic 
response and the increased level of cleaved caspase-3 in both H U V E C s and 
R A E C s following B M P 4 insult. 
Although the biological effects of TGF-ps, B M P s and activins are reported 
to be mediated through the activation of S m a d signaling cascade, B M P s were 
also found to activate the M A P K s in several types of cells. For example, B M P 2 
together with IL6 trigger apoptosis of mouse hybridoma cells via p38 M A P K 
activation (Kimura et al. 2000). Moreover, B M P 4 induced the expression of 
heme oxygenase-1 through MAPKs-dependent mechanisms in pulmonary 
artery myocytes (Yang et al. 2007) and activated Smadl, p38 M A P K and E R K 
in pulmonary V S M C (Yang et al. 2005). 
Furthermore, M A P K s pathways are involved in endothelial cell apoptosis 
(Fu et al. 2006). However, the present study is probably the first one to 
demonstrate that the activation of both p38 M A P k and J N K contributes to 
BMP4-induced endothelial cell apoptosis. B M P 4 stimulated the p38 M A P K 
activity after 2-hour exposure of endothelial cells to B M P 4 (Fig 3.26) while 
activation of J N K 1 was detected 4 hours after B M P 4 challenge (Fig 3.27), with 
knockdown effect of JNK1 siRNA on H U V E C s showing that completely 
knockdown the JNK1 activity could totally restore the elevated caspase-3 
cleavage (Fig 3.34) after B M P 4 exposure, thus suggesting the possible 
mechanism that J N K 1 activation play a key role and was downstream to the 
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p38 M A P K activation in BMP4-treated endothelial cells. Nevertheless, further 
studies are needed to elucidate the possible relationship between S m a d and 
M A P K s pathway in BMP4-induced endothelial cell apoptosis. 
3.4.4) ROS mediates BMP4-induced activation of MAPKs 
The present study confirms that B M P 4 is able to increase R O S generation 
through activation of apocynin-sensitive NAD(P)H oxidase. Fig 3.17 shows a 
rapid production of R O S after 30-min exposure of rat endothelial cells to B M P 4 . 
This response occurs earlier than activation of M A P K s , suggesting that R O S 
m a y act as an upstream activator for p38 M A P K (2-hour exposure is needed) 
and J N K (4-hour exposure is needed) before the induction of endothelial cell 
apoptosis (24-hour B M P 4 exposure is required). 
Growing evidence indicates that R O S and M A P K s are involved in 
endothelial dysfunction under different pathological conditions (Lopez Farre 
and Casado 2001). M A P K s are the downstream target of ROS-induced 
apoptosis in renal proximal tubule epithelial cells，pancreatic acinar cells and 
cardiac cells (Yoshizumi 2001，Ramachandiran et al. 2002, Dabrowski et al. 





p38 M A P K , E R K and J N K in rat V S M C s and P C 12 cells (Guyton et al. 1996). 
R O S mediates J N K activation in cardiomyocyte apoptosis in a ferret model of 
congestive heart failure (Qin 2003). In the present study, the role of R O S in 
activation of p38 M A P K and J N K was first demonstrated in R A E C s as the 
NAD(P)H oxidase inhibitor (apocynin) and R O S scavengers (tiron plus D E T C A ) 
could effectively suppress the phosphorylation of p38 M A P K and J N K (Fig 
3.28 and 3.29). Taken together, BMP4-mediated R O S generation leads to 
activation of p38 M A P K and J N K and subsequently to endothelial cell 
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apoptosis. 
3.4.5) Role of p38 MAPK in the activation of JNK 1 
The present study has provided evidence on a crosstalk between p38 M A P K 
and J N K 1 in BMP4-induced endothelial cell apoptosis. Both p38 M A P K 
inhibitor (SB 202190) and JNK inhibitor (SP 600125) can fully reverse the 
elevated apoptotic rate induced by B M P 4 , indicating both M A P K s may interact 
with each other. To further understand how p38 M A P K and J N K may interact, 
R A E C s were treated with either S B 202190 (p38 M A P K inhibitor) or S P 
600125 (JNK inhibitor) for 30 minutes prior to B M P 4 exposure. Western blot 
results show that the activation of JNK 1 reflected by the level of 
phosphorylation was attenuated by the p38 M A P K inhibitor. By contrast, the 
p38 M A P K phosphorylation was unaltered by the J N K inhibitor (Fig 3.30 and 
3.31). Given the fact that p38 M A P K activation as determined by the 
time-course experiment occurs about two hours earlier than that of JNK, the 
present results clearly suggest that activation of J N K is the downstream event 
of the p38 M A P K phosphorylation. 
R O S plays a positive role in the activation of J N K and p38 M A P K in 
H U V E C s (Ho et al. 2008, Guyton et al. 1996), suggesting that p38 M A P K and 
J N K are redox sensitive. The present study show that R O S generated due to 
BMP4-activated NAD(P)H oxidase could activate p38 M A P K and J N K by 
increasing the level of phosphorylation for both M A P K s . Since the elevated 
apoptotic rate was abolished by inhibitors of both p38 M A P K and JNK, it is 
possible that p38 M A P K and JNK may utilize a similar signaling cascade in 
endothelial cells in response to B M P 4 . Based on available information in 
literature, M A P K crosstalk is reported to be important in fluid shear 
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stress-induced endothelial responses. For instance, the activation of J N K by 
shear stress was abolished by pharmacological inhibition of E R K , indicating 
that E R K regulates the J N K activity in H U V E C s (Surapisitchat et al. 2001). 
Likewise, the present results demonstrate that p38 M A P K is likely responsible 
for the regulation of J N K activity in BMP4-induced intracellular events leading 
to apoptosis of R A E C s . I have thus provided the first line of evidence showing 
a cross-regulation between p38 M A P K and J N K in endothelial cells. 
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3.5) Concluding remarks 
The results of the present investigation demonstrate an intracellular sequence 
of events involved in BMP4-induced apoptosis of both rat and human 
endothelial cells according to different time-course of each cellular response 
and confirmed by the use of pharmacological inhibitors (Fig. 3.32). B M P 4 
triggers overproduction of R O S , which in turn activates p38 M A P K . Increased 
activity of p38 M A P K activates J N K 1 leading to an increased level of cleaved 
caspase 3 leading to endothelial cell apoptosis. The elevated R O S production 
is likely derived from NAD(P)H oxidase as apocynin inhibits such increase. 
Up-regulation of the caspase-3 expression accounts for the increased 
apoptotic rate in both rat and human endothelial cells. Noggin can completely 
antagonize all aforementioned effects of B M P 4 in endothelial cells. Moreover, 
R O S production by B M P 4 is a very rapid process, which is likely to act among 
initial triggering signals resulting in caspase-3-dependent endothelial cell 
apoptosis in response to B M P 4 . Finally, the present study also provides novel 
evidence for a crosstalk between p38 M A P K and J N K with the former 
regulating the activity of the latter in endothelial cells. 
In a short summary, the present study has thus provided a likely 
mechanism through which B M P 4 causes endothelial cell apoptosis and this 
effect m a y participate in vascular inflammation and ultimately leads to the 
initiation and development of cardiovascular dysfunction. Further examinations 
are required in order to deepen our understanding of other roles of B M P 4 in 
cardiovascular pathogenesis and to search for therapeutic intervention that 
specifically targets B M P 4 signaling transduction pathway if B M P 4 turns out to 
be another reliable biomarker of vascular dysfunction. 
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Figure 3.32. The schematic diagram proposing a mechanism for the 
BMP4-induced endothelial cell apoptosis. Exogenous B M P 4 activates 
NAD(P)H oxidase (probably through B M P 4 receptor) to release superoxide 
anions (0
2
-'). leading to the activation of p38 M A P K and then J N K 1, resulting 
in the activation of caspase-3 and subsequent endothelial cell apoptosis. 
Noggin, the B M P 4 antagonist prevents the apoptotic effect of B M P 4 . S B 
202190 and S P 600125 inhibit the phosphorylation of p38 M A P K and JNK, 
respectively. B M P 4 , bone morphogenic protein-4; B M P R , B M P receptor; 0
2
-", 
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